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1. Abbreviations 
 
AHI Apnea-hypopnea index 
AI Apnea index 
BiPAP Bi-level pressure support 
BMI Body mass index  
COPD Chronic obstructive pulmonary disease 
CPAP Continuous positive airway pressure 
CSB Cheyne-Stokes breathing 
EEG Electro-encephalogram  
EMG Electro-myogram  
EOG Electro-oculogram  
EPAP Expiratory positive airway pressure  
FVC Forced vital capacity 
HI Hypopnea index 
HMV Home mechanical ventilation  
IPAP Inspiratory positive airway pressure  
NIV Non-invasive ventilation 
NPPV Nasal positive pressure ventilation 
ODI Oxygen desaturation index 
OHS Obesity-hypoventilation syndrome  
OSA Obstructive sleep apnea  
PB Periodic breathing  
PBI Periodic breathing index 
PEEP Positive end-expiratory pressure  
PEEPe Extrinsic positive end-expiratory pressure  
PEEPi Intrinsic positive end-expiratory pressure  
PEEPidyn Dynamic PEEPi  
PM Poly-MESAM  
PS Pressure support 
PSG Polysomnography  
PTPes Esophagal pressure-time product  
PVA Patient-Ventilator Asynchrony 
RDI Respiratory disturbance index  
QoL Quality of life 
REM Rapid eye movement sleep 
RR Respiratory rate  
S/T Spontaneous/timed  
S1 Stage 1 sleep 
S2 Stage 2 sleep 
S3-4 Stage 3-4 sleep 
SaO2 Arterial oxygen saturation  
SaO2 min Minimum arterial oxygen saturation 
SaO2 mean Mean arterial oxygen saturation 
SE Sleep efficiency  
SL  Sleep latency 
SWS Slow wave sleep  
TcPCO2 Transcutaneous carbon dioxide tension  
TE Expiratory time  
TI Inspiratory time  
TMA Total micro arousals 
TST Total sleep time  
WASO Wake after sleep onset 
ΔRR (p-v) Difference between patient and machine respiratory rate 
   
 
 2. Summary in French – Résumé en français 
2.1 Introduction : 
Le concept de ventilation non-invasive (VNI) comprend tout mode d’assistance 
ventilatoire ne nécessitant ni intubation oro-trachéale ni trachéotomie. Au cours de la 
première moitié du XXè siècle, la ventilation en pression négative (poumon d’acier) 
était le mode principal de support ventilatoire au long cours. Dans les années 60’, la 
ventilation en pression positive a progressivement remplacé la ventilation en pression 
négative, notamment à cause de son moindre encombrement, et de son efficacité 
accrue chez des sujets ayant des apnées obstructives. Initialement, la ventilation en 
pression positive était de type volumétrique (volume courant imposé) ; plus 
récemment, des appareil barométriques à 2 niveaux de pression, plus légers, se sont 
avérés efficaces dans la prise en charge de patients souffrant d’insuffisance 
respiratoire hypercapnique d’origine restrictive (cyphoscoliose, maladies 
neuromusculaires, syndrome obésité-hypoventilation alvéolaire), ou obstructive 
(COPD, asthme, mucoviscidose), dans les suites de traumatismes, et post-extubation. 
Le principe de ces appareils est de fournir à la fois une attelle pneumatique (pression 
positive continue dans les voies aériennes), et une aide inspiratoire (différence entre la 
pression inspiratoire ou IPAP, et la pression expiratoire ou EPAP, fixés par le 
clinicien) ; ces appareils sont de plus conçus pour compenser les fuites ce qui facilite 
leur utilisation de manière non-invasive. 
La VNI a connu au cours des 15 dernières années un essor important, notamment aux 
U.S.A, en France, et en Suisse. En Suisse par ex., le nombre total de patients sous 
ventilation à domicile, tous modes confondus, est passé de 46 (1989) à 876 (juin 
2004). Moins de 5% font l’objet d’une ventilation par trachéotomie. 
2.2 Indications : 
L’efficacité de la VNI est bien établie dans l’insuffisance respiratoire hypercapnique 
liée aux troubles statiques de la cage thoracique (cyphoscoliose, séquelles de 
thoracoplastie), et aux maladies neuromusculaires (myopathies, syndromes post-
poliomyélite), avec un effet favorable notamment sur les symptômes, et la ventilation 
alvéolaire nocturne. La BPCO est devenue une indication fréquente à la VNI, bien 
que beaucoup plus controversée : deux sous-groupes bénéficient cependant de la 
VNI : les sujets les plus hypercapniques, et ceux porteurs d’un « overlap syndrome » 
(patients BPCO ayant un syndrome d’apnées obstructives du sommeil, souvent 
obèses). Des études longitudinales ont montré un effet favorable de la VNI sur la 
fréquence et la durée des hospitalisations – bien qu’à un degré moindre lors de BPCO 
- suggérant un impact favorable de la VNI en termes de coûts de la santé.  
Le syndrome obésité-hypoventilation (SOH) est défini par l’association d’une obésité 
morbide, et d’une hypercapnie diurne, sans autre facteur explicatif. Plusieurs facteurs 
contribuent à la pathogenèse de ce syndrome : l’augmentation de la résistance des 
voies aériennes et du travail respiratoire nocturne liée à un syndrome d’apnées 
obstructives du sommeil fréquemment associé, une possible diminution du « drive » 
ventilatoire, et la contrainte mécanique liée à l’effet de l’obésité sur la compliance du 
système respiratoire. Bien que le traitement de choix du SOH soit la perte de poids, 
les tentatives de perte pondérale échouent souvent. Le traitement de choix est alors la 
VNI, avec un impact favorable démontré sur l’hypercapnie et l’hypoxémie diurnes et 
nocturnes. Actuellement, en Suisse Romande, le SOH représente l’indication la plus 
fréquente à la mise en route d’une VNI. 
Les complications de la VNI sont rares : lésions cutanées, distention gastrique, 
irritation conjonctivale, otalgies ou douleurs des sinus.  
2.3 Interactions patient-ventilateur : 
L’échec de la VNI (correction insuffisante de l’hypoxémie et de l’hypercapnie) peut 
être consécutif à l’incapacité du patient à tolérer la pression positive, à un sentiment 
de claustrophobie, d’étouffement, ou à des troubles des fonctions supérieures 
(agitation, confusion). Toutefois, la cause la plus importante d’échec de la VNI réside 
dans la désynchronisation entre patient et ventilateur. La désynchronisation peut 
résulter d’une diminution de la commande des centres respiratoires (« drive »), en 
particulier lorsque le paramétrage du déclenchement inspiratoire de l’appareil est 
inadéquat (« trigger »). La non-concordance entre le cycle respiratoire du patient et 
celui du ventilateur peut aussi contribuer à l’inefficacité ou à l’échec de la 
ventilation : aide inspiratoire insuffisante, travail respiratoire non diminué, voire accru 
en raison d’une pressurisation asynchrone. Dans la BPCO, l’hyper-inflation 
dynamique, et la présence d’une pression positive en fin d’expiration dans les voies 
aériennes (« auto-PEEP ») peut augmenter l’effort du patient pour déclencher le 
ventilateur et participer à une désynchronisation patient-ventilateur. 
Des modifications technologiques apportées aux ventilateurs récents contribuent à 
améliorer la synchronisation patient-ventilateur : déclenchement inspiratoire (trigger) 
lié au flux inspiratoire du patient et non plus aux changements de pression, 
synchronisation expiratoire (« cyclage ») ajusté aux variations de flux inspiratoire et 
paramétrable, logiciels sophistiqués (par ex : système « Auto-track », Respironics). 
2.4 Outils pour le monitoring de la VNI au long cours : 
Les outils d’utilisation courante pour le monitoring de l’adéquation de la ventilation 
sont l’oxymétrie nocturne, et, dans certains centres, la capnographie trans-cutanée. La 
polysomnographie, considérée comme « l’étalon or » pour la détection des troubles 
respiratoires pendant le sommeil, est plus rarement utilisée dans cette indication. Le 
développement de la polygraphie, outil validé dans la détection des apnées 
obstructives ou centrales, offre une perspective intéressante et moins onéreuse dans le 
monitoring de patients sous VNI. 
2.5 Buts de l’étude : 
1. Analyser la contribution de la polygraphie (PG) et de la polysomnographie (PSG) 
dans la détection d’évènements respiratoires tels que : désynchronisation entre patient 
et ventilateur, ou survenue d’une respiration périodique, évènements qui ne sont pas 
nécessairement associés à une chute de la SaO2 ou à une augmentation de la PCO2
2. Quantifier la fréquence des évènements respiratoires survenant sous VNI et décrire 
leur association avec les stades de sommeil 
3. Décrire l’efficacité de la VNI (en termes de correction de l’hypoventilation 
alvéolaire), et la qualité du sommeil chez des patients sous VNI au long cours pour 
SOH 
4. Analyser l’association entre les évènements respiratoires, les micro-éveils, les 
désaturations et les fluctuations de la capnie  
5. Démontrer la validité de la polygraphie en tant qu’outil de monitoring ambulatoire 
de la VNI lors de SOH 
2.6 Patients et méthodes 
Des patients en état stable, traités ambulatoirement depuis au moins 3 mois par VNI à 
l’aide d’un appareil barométrique à 2 niveaux de pression pour un SOH, ont été 
recrutés. Tous les patients avaient eu au moins un épisode de décompensation 
hypercapnique avant la mise sous VNI. L’indication à la VNI avait été approuvée par 
un groupe d’experts de la Société Suisse de Pneumologie, selon les recommandations 
nationales en vigueur. Ont été exclus, les patients non-compliants ou souffrant d’une 
BPCO, d’un cœur pulmonaire décompensé, d’une insuffisance cardiaque, rénale, 
hépatique, d’une affection neuromusculaire, ou de troubles cognitifs. Le protocole a 
été accepté par la Commission d’Ethique sur la Recherche des HUG. 
2.7 Structure de l’étude : 
Au cours d’une nuit passée au Centre du Sommeil de Belle-Idée, HUG (Genève), les 
patients ont été équipés simultanément d’une polysomnographie (MAP, Germany), 
d’une polygraphie (PolyMESAM, ibid.), et d’un capnographe (mesure trans-cutanée 
du CO2, Radiometer Tina TCM III). Les enregistrements ont été effectués sous VNI, 
l’interface étant équipé d’un capteur de pression pour l’enregistrement 
polysomnographique, et d’un pneumo-tachographe pour le polygraphe. 
2.8 Paramètres analysés : 
L’analyse de la polysomnographie (PG) et de la polysomnographie (PSG) a permis 
d’établir l’index d’apnées (IA), l’index d’hypopnées (IH), l’index d’apnées-
hypopnées (IAH), la saturation en oxygène (SaO2) moyenne, et minimale, le % du 
temps total passé avec une SaO2 < 90%. En présence d’une respiration périodique 
(alternance d’apnées ou d’hypopnées de type central et de phases d’hyperventilation), 
un index de respiration périodique (PBI) a été calculé (nombre d’apnées ou 
d’hypopnées/heure) de même que le pourcentage du temps total passé en respiration 
périodique. La valeur transcutanée moyenne et médiane du CO2 (TcPCO2), de même 
que le graphique de la TcPCO2 en fonction du temps, ont été analysés. L’architecture 
du sommeil a été analysée selon les critères de Rechtschaffen et Kales, permettant de 
définir les stades I, II, III-IV (sommeil lent profond), et REM, ainsi que l’index de 
micro-éveils (arousals). Cinq évènements ont été définis pour analyser l’interaction 
entre patient et ventilateur : les désynchronisations, les chutes de pression inspiratoire 
–suggérant des fuites importantes-, l’auto déclenchement, les efforts inspiratoires 
non-recompensés, et les fuites (analysées sur la base d’une constellation d’éléments 
suggestifs). 
2.9 Résultats : 
Huit femmes et 12 hommes, âgés de 64±12 ans, ayant un IMC de 43±7 kg/m2, ont été 
étudiés (Tableau 1). L’architecture du sommeil était altérée chez la plupart des 
patients, avec une augmentation du stade I (en % du temps de sommeil total), un 
index de micro-éveils augmenté (26±9/hr.), une diminution du sommeil REM 
(14±6%), et de l’indice d’efficacité du sommeil (71±10%)(Tableau 2). La plupart des 
micro-éveils (90%) survenaient au cours des stades I-II (Tableau 3). L’IAH était dans 
l’ensemble satisfaisant (5±5/hr.), avec 4 patients seulement ayant un IAH > 10. 
L’index de désaturations était de 7±6/heure ; la SaO2 moyenne était de 91±3%, avec 
un nadir à 80±7%. La TcPCO2 était dans la norme (43±6 mmHg, soit 5.7±0.5 kPa). Il 
n’y avait aucune corrélation entre la SaO2 moyenne ou minimale et la TcPCO2 
suggérant que l’hypoxémie n’était pas consécutive à une hypoventilation alvéolaire. 
Désynchronisation patient-ventilateur : 
Onze patients (55%) présentaient des épisodes répétés de désynchronisation avec leur 
ventilateur : ces épisodes représentaient 31±24% du temps total de sommeil (Tableau 
4). Les résultats obtenus par PG et PSG étaient fortement concordants (r=.84, 
p=.001). La répartition du temps passé avec une désynchronisation patient-machine 
en fonction des stades de sommeil figure dans le Tableau 5, 58% survenant en stade I-
II, 22% en sommeil lent profond (III-IV), et 20% en REM. Il n’y avait aucune 
différence entre patients avec et sans épisodes répétés de désynchronisation quant à la 
SaO2, l’index de désaturations ou la TcPCO2 (Tableau 6). Toutefois, la 
désynchronisation était clairement associée à un sommeil de moindre qualité : plus de 
sommeil léger, plus d’éveils, moins de sommeil lent profond et REM (Tableau 6). Au 
cours des stades I-II, 68% des micro-éveils étaient associés à des épisodes de 
désynchronisation ; toutefois, au cours des stades III-IV et REM, en dépit de 
fréquents épisodes de désynchronisation, peu étaient associés à des micro-éveils. 
Respiration périodique : 
Huit patients (40%) présentaient un indice de respiration périodique (RP) > 5/heure ; 
la RP représentait en moyenne 6.3±4% du temps de sommeil total. La plupart de ces 
évènements (81%) survenaient en stade I-II ; peu étaient associés à des micro-éveils 
(Tableau 10). Alors que les patients avec RP avaient une SaO2 minimale plus basse et 
un index de désaturation plus élevé, la TcPCO2 était similaire dans les groupes avec et 
sans RP (Tableau 11). Il n’y avait pas non plus de relation entre paramétrage du 
ventilateur (et donc flux généré par le ventilateur) et RP. Comme pour les épisodes de 
désynchronisation, la concordance entre PG et PSG était excellente pour la RP (r=.90, 
p=.002). 
Fuites buccales et chute de pression inspiratoire: 
La somme d’indices considérés comme suggestifs de fuites buccales s’est avérée 
d’analyse difficile, et peu sensible dans la détection des fuites. De fait, la chute de 
pression inspiratoire est probablement le marqueur le plus spécifique de fuites 
buccales importantes, quoique peu sensible. 
Auto-déclenchement : 
La survenue de brefs épisodes d’auto déclenchement était fréquente ; une seule 
patiente avait des épisodes (asymptomatiques) d’auto déclenchement pendant plus de 
10% de son enregistrement. 
2.10 Commentaires et conclusions: 
Ce travail est à notre connaissance le premier à analyser la structure du sommeil et les 
interactions patient-ventilateur dans un groupe de patients sous VNI pour un 
syndrome obésité-hypoventilation. Les résultats obtenus montrent que, en dépit d’un 
contrôle acceptable de la SaO2 et adéquat de la TcPCO2 (« end-points » principaux du 
support ventilatoire nocturne), des épisodes de désynchronisation patient-ventilateur, 
parfois prolongés, surviennent fréquemment (55% des patients). Ces épisodes 
s’associent à des altérations importantes de la qualité du sommeil : diminution du 
sommeil profond et du sommeil REM, augmentation des micro-éveils, et association 
fréquente entre micro-éveils et périodes de désynchronisation, en particulier en stade 
I-II. En sommeil profond, les épisodes de désynchronisation semblent moins induire 
de micro-éveils. L’impact sur le sommeil de la désynchronisation patient-machine 
pourrait avoir un effet délétère sur la compliance, le confort, et les symptômes 
diurnes, et donc sur la qualité de vie du patient.  
L’analyse des tracés suggère que, lors d’asynchronie patient-machine, non seulement 
le ventilateur ne diminue pas le travail respiratoire, mais celui-ci pourrait être par 
moments augmenté : par exemple, lors de cyclage tardif, l’expiration se fait contre la 
pression d’IPAP (pression inspiratoire maximale fixée par le clinicien). Il est 
intéressant de noter le peu d’impact de ces évènements – dans cette population très 
ciblée – sur la SaO2 et la TcPCO2. 
D’autres évènements respiratoires (respiration périodique, apnées ou hypopnées 
centrales, limitations de flux) ou évènements-machine (auto-déclenchement), 
surviennent fréquemment, le plus souvent à l’insu du patient, et semblent toutefois 
avoir moins de conséquences sur l’architecture du sommeil. Contrairement à 
l’hypothèse initiale, la respiration périodique ne semblait associée ni à l’hypocapnie 
induite par la ventilation (pas de différence pour la TcPCO2 entre patients avec et sans 
RP), ni à un paramétrage-machine induisant un flux inspiratoire élevé (pressions 
inspiratoires et expiratoires similaires chez les patients avec ou sans RP). Elle 
s’associait toutefois à des désaturations plus fréquentes et à une SaO2 minimale plus 
basse. 
Bien que le but premier de la VNI au long cours soit la correction de 
l’hypoventilation alvéolaire, la détection d’évènements délétères sur la structure du 
sommeil paraît nécessaire pour l’amélioration de la qualité des soins et du confort du 
patient. La contribution de la PG ou de la PSG est donc importante dans la prise en 
charge et l’ajustement de la VNI au long cours. 
Tant pour la détection de l’asynchronie patient-machine que pour celle de la 
respiration périodique, la polygraphie et la polysomnographie ont montré des résultats 
hautement concordants. La lacune majeurs de ces 2 outils était l’absence de mesure 
objective des fuites. Par contre, l’apport du pneumo-tachographe, dont était équipé le 
polygraphe de cette étude, s’avère améliorer nettement l’analyse fine des interactions 
patient-machine par rapport au tracé de PSG, qui – utilisé ici dans sa configuration 
« par défaut » – ne comprend qu’un capteur de pression. 
En résumé, la PG et la PSG permettent la détection d’évènements respiratoires et 
d’interactions patient-machine ayant des répercussions mesurables sur la qualité du 
sommeil, et donc potentiellement sur la qualité de la VNI au long cours (tolérance, 
compliance, impact sur les symptômes).  
 3. Introduction 
Non-invasive ventilation (NIV) refers to the delivery of mechanical ventilation to the 
lungs using techniques that do not require an endotracheal tube or a tracheostomy. 
During the first half of the XX  century, negative pressure ventilation was the main 
means of providing long term non-invasive mechanical ventilatory assistance. By the 
1960’s, however, invasive positive pressure ventilation superseded negative pressure 
ventilation even for long term care, primarily because of a less cumbersome 
equipment, and increased efficiency in patients at risk for upper airway collapse and 
obstructive sleep apnea such as patients with neuro-muscular diseases (1). The past 
twenty years have seen a increase in the use of NIV, largely because of the 
development of nasal positive pressure ventilation, which has the potential of 
providing ventilatory assistance with greater convenience, comfort, safety, and at a 
lesser risk than invasive ventilation. Several authors have reported successful NIV 
utilizing volume-cycled ventilators (2, 3). More recently, bi-level positive airway 
pressure via mask has been effectively utilized to provide NIV to patients with acute 
or chronic hypercapnia due to restrictive/neuromuscular diseases, chest wall 
deformity (4), COPD (5), sleep apnea (6, 7), cystic fibrosis (8), asthma (9), trauma 
(10), post-extubation to faciliate weaning (11) and obesity-hypoventilation syndrome 
(OHS) (12, 13). Bi-level positive airway pressure provides inspiratory positive airway 
pressure (IPAP) and expiratory positive airway pressure (EPAP), each of which can be 
independently adjusted to augment alveolar ventilation and maintain upper airway 
pressure patency; the devices are designed to compensate for mild-to-moderate mouth 
or interface leaks, which facilitates non-invasive application. 
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3.1 Demographics 
Adams found that NIV was responsible for 47% of the increase in the number of 
chronic ventilator-assisted subjects in Minnesota (USA) between 1992 and 1997 (14).  
The 1998 report of the “Association Nationale pour le Traitement à Domicile de 
l’Insufficance Respiratoire Chronique” Observatory (ANTADIR, French national 
database) shows that the use of NIV increased almost exponentially as of 1988, with 
500 persons receiving NIV in 1990, 3000 by 1996 and 4500 in 1998 
(www.antadir.com). In Switzerland, at the end of 1989, 46 patients were receiving 
home mechanical ventilation (HMV; 30% used NPPV). At present, approximately 
870 patients are receiving NPPV in Switzerland (June 2004, personal communication, 
SSP), with 155 being treated in the Geneva Lake area (i.e., a prevalence of 15 per 10  5
inhabitants)(13). 
3.2 Common Clinical Indications for NIV 
3.2.1 Chest wall and Neuromuscular disorders 
It is clear that NIV (with either pressure or volume-cycled ventilators) can effectively 
reduce daytime PaCO  in patients with chest wall or neuromuscular disorders who 
have chronic hypercapnia. Present guidelines recommend that ventilatory support be 
initiated in symptomatic patients with either a daytime PaCO > 6 kPa (45 mmHg), or 
more than 5 min spent asleep with an arterial oxygen saturation (SaO ) < 88%(15). 
After treatment with NIV, breathlessness on exertion, quality of sleep, daytime 
sleepiness and fatigue, and early-morning headaches are improved (16). Activities of 
daily living, such as shopping, cooking and cleaning, may be carried out with less 
difficulty than before; adults may be able to return to work (17).  Long-term 
ventilatory support has been shown to reduce the number of days spent in hospital (18, 
19) and improve psychosocial and mental function (20). Sleep architecture(21), 
oxygen saturation and transcutaneous TcPCO  during sleep, as well as daytime 
arterial blood gases, improve often within the first few days of treatment(19, 22, 23). 
Small improvements in vital capacity, functional residual capacity, maximum 
inspiratory and expiratory mouth pressures, inspiratory muscle endurance and 
respiratory drive have also been described (17). In a 3-month prospective controlled 
trial, Schonhofer et al (24) showed a significant improvement in endurance time in 
three different tests in the NPPV group compared with controls. Endurance time 
increased on average by 278±269% during an inspiratory threshold loading test, by 
176±159% during a cycle ergometer test, and by 32±22% during a shuttle walking 
test. Pulmonary haemodynamics have also been shown to improve significantly after 
1 yr of NPPV in patients with chest wall deformity (25).  
2
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3.2.2 COPD  
In contrast to the consistently favorable results of studies on the use of NIV in 
patients with restrictive pulmonary disease, those on patients with severe obstructive 
lung disease yield conflicting results. A review of these studies is beyond the scope of 
the present study. However, the long-term follow-up study by Leger et al (26) found 
not only a sustained reduction in PaCO  in patients with severe COPD but also a 
significant drop in hospital days for 2 years after starting NPPV. A similar finding was 
recently reported by Janssens et al (13) who found that NPPV decreased the number 
of hospitalizations for cardiac or respiratory failure in patients with hypercapnic 
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COPD for up to 2 years and thus may improve QoL. These latter studies suggest that 
the effect of NPPV on health resource utilization in severe COPD deserves 
examination. The conflicting results of studies on the use of NIV for severe stable 
COPD make it virtually impossible to assemble guidelines based on solid evidence. 
Nevertheless, a number of inferences can be drawn. First, NPPV appears to be well 
tolerated in this patient population. Ease of administration, potentially favorable 
effects of EPAP on intrinsic PEEP and work of breathing, as well as the ability to 
eliminate obstructive sleep apneas (overlap syndrome, present in 15% of COPD) 
makes NPPV the noninvasive mode of first choice. Patients with little or no CO  
retention, regardless of the severity of airway obstruction, appear to gain little or no 
benefit from NIV. This may be because these patients tend to have less nocturnal 
hypoventilation and fewer episodes of sleep-disordered breathing in the first place, 
and have less to gain from nocturnal ventilatory assistance. Also, respiratory muscle 
fatigue is probably not an important contributing factor at rest during periods of 
clinical stability. Rather, the studies suggest that if any patient subpopulation is likely 
to benefit, it is those with substantial daytime CO  retention. This contention is 
supported by the fact that average initial PaCO  values were 10 mm Hg higher (57 vs 
47 mm Hg) among studies using negative pressure ventilation that showed a clinical 
benefit compared to those showing none (27, 28).  
2
2
2
In conclusion, although the evidence is conflicting and far from definitive, COPD 
patients with severe CO  retention appear most apt to respond favorably to nocturnal 
NPPV.  
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3.2.3 Obesity-hypoventilation syndrome (OHS) 
 
 
The obesity-hypoventilation syndrome (OHS) 
is characterized by the association of morbid 
obesity and daytime hypercapnia in the 
absence of an alternative neuromuscular, 
mechanical, or metabolic explanation for 
alveolar hypoventilation. It was originally 
described in 1955, in subjects with obesity, 
chronic daytime hypercapnia and hypoxemia, 
polycythaemia, hypersomnolence and right 
ventricular failure (29). In 1956, Burwell et al 
(30) coined the term “Pickwickian syndrome” 
for these patients because of their 
ressemblance with the messenger-boy Joe in 
Charles Dickens' 'The Pickwick Papers'.  
 
OHS is the most rapidly growing group of patients with chronic respiratory failure. 
There are two major factors contributing to the pathogenesis of OHS: obstructive 
sleep apnea and obesity. 
Obstructive sleep apnea — A commonly recognized factor contributing to OHS is 
severe obstructive sleep apnea (OSA). In a prospective study, Kessler et al (31) 
reported on the differences between OHS patients, those with 'pure' OSAS and those 
with a combination of COPD and OSAS (“overlap syndrome”). This study showed 
that OHS patients were on average older, and more obese. They had more deranged 
daytime arterial blood gases (hypoxaemia, hypercapnia), a more severe restriction in 
lung function, and more severe arterial oxygen desaturations during sleep. They also 
had higher pulmonary artery pressures and pulmonary vascular resistance than 
patients with only OSAS. There are, however, a number of factors that, when 
superimposed upon OSAS, predispose such individuals to develop OHS. These 
include: a high frequency of apneas and hypopneas during sleep (32), a high 
frequency of episodes of oxyhemoglobin desaturation during sleep (33); a low forced 
vital capacity (34); a low FEV  (32); a small upper airway by computed tomographic 
(CT) measurements (33); a low arterial oxygen tension (PaO ) during wakefulness 
(33) and heavy alcohol intake (33). 
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Most of the above factors predispose to OHS because they cause or reflect an 
increased work of breathing. As an example, apneas, hypopneas, and episodes of 
oxyhemoglobin desaturation reflect upper airway occlusion during sleep and thus 
increased airway resistance. Massive obesity (which may produce a low FVC) and 
COPD (which may produce a low FEV , with or without an accompanying low FVC) 
are each associated with increased work of breathing. Heavy alcohol intake also 
contributes to the development of OHS, presumably by depressing ventilatory drive. 
1
Obesity — Not all patients with OHS have OSA, as some hypoventilate during sleep 
in the absence of discrete episodes of apnea or hypopnea (31). Few of these patients 
have been described, and the cause of their hypoventilation has not been investigated. 
Some were carefully studied before it was appreciated that sleep apnea could be a 
significant etiologic factor. It has therefore been difficult to sort out which effects of 
obesity are mediated by and which are independent of an associated OSAS. 
The observation that weight loss uniformly decreases the waking PaCO  in patients 
with OHS illustrates the pathogenic importance of obesity. There are numerous 
consequences of obesity that may relate to OHS, including effects on compliance and 
impedance of the respiratory system, ventilation-perfusion mismatching, respiratory 
muscle function, and ventilatory drive. 
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However, the following observations suggest that factors other than obesity also play 
a contributory role. First, most morbidly obese patients do not become hypercapnic 
and, in those who do, there is no correlation between the degree of obesity and the 
ventilatory abnormalities (35) Second, an improvement in ventilatory pattern can be 
produced in some patients with progesterone (a respiratory stimulant) (36): this 
finding indicates that these patients can increase their alveolar ventilation and raises 
the possibility of an associated central defect. 
In summary, the pathogenesis of OHS is more likely to be a multifactorial disorder 
involving the chest wall, respiratory muscles and ventilatory drive. Body weight, as 
such, does not correlate with chronic daytime hypercapnia, although weight loss in 
OHS patients can reverse daytime hypercapnia (37).  
Treatment of OHS 
The first line of treatment of OHS is weight loss. This can be achieved with dietetic 
programs. As a rule, weight loss reverses the respiratory failure, and in addition treats 
the other diseases associated with obesity. However, the majority of patients with 
OHS do not lose enough weight, or if they do, they regain it rather quickly. Surgery 
for obesity is another therapeutic choice. Unfortunately, respiratory failure is 
considered as a poor prognostic factor for upper-abdominal surgery of obese patients.  
NIV is the other treatment choice for OHS, and it has increased markedly in the past 
10 years. One study evaluated the effectiveness of NIV on nocturnal oxygen 
desaturation in 11 obese patients without daytime respiratory failure. NIMV was 
compared with the effect of the "gold standard" treatment, nocturnal oxygen. The 
results obtained were compared with those of a group of 10 patients with restrictive 
chest wall disease (mainly kyphoscoliosis) who received the same treatment protocol. 
In both groups, daytime PO  improved significantly. Nocturnal oxygen saturation and 
PaCO  also improved when the patients were treated with NIMV. Treatment with 
nocturnal oxygen only succeeded in improving nocturnal oxygenation, but in contrast 
to NIMV, there was a tendency for nocturnal PaCO  to increase (38). Masa et al (12) 
compared the effectiveness of 4 months of treatment with NIMV in 22 OHS and 14 
kyphoscoliotic patients. They found that frequency of symptoms, such as morning 
headache, morning drowsiness, dyspnea, and leg edema, improved significantly in 
both groups of patients. Sleepiness improved only in the OHS group. One report, 
evaluated the efficacy of NIPPV in 13 patients who were massively obese and had 
persistent daytime hypercapnia after nasal CPAP. NIPPV (for seven to 18 days) led to 
a fall in PaCO  (from 62 to 46 mmHg) and a rise in PaO  (from 50 to 66 mmHg). 
Nine of the patients were able to maintain their lower PaCO  values after being 
switched back to nasal CPAP (39).  
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In conclusion, the improvement in clinical symptoms and respiratory failure of 
patients with OHS by NIV is quite similar to that reported in kyphoscoliosis, a disease 
for which the use of long term NIV is completely established. The results of these 
studies also suggest that the surgical prognosis in obese patients with hypercapnic 
respiratory failure could improve if those patients were treated preoperatively with 
NIV.  
3.3 Complications of Noninvasive Ventilation 
The primary complication of NIV is focal skin necrosis secondary to prolonged 
pressure from the mask on the underlying skin. This typically occurs over the bridge 
of the nose but may also occur over the zygomatic arch, and is prevented by avoiding 
excessive pressure when tightening the straps holding the mask. The other 
complications all seem to occur less frequently and include gastric distention (avoided 
by ventilating with pressures below 30 cm H O), or aspiration in subjects with glottic 2
dysfunction. Other adverse effects related to air flow or pressure include conjunctival 
irritation caused by air leakage under the mask into the eyes and sinus or ear pain 
related to excessive pressure. 
3.4 Patient-ventilator interactions 
Failure of NPPV has been reported in 7 to 42% of patients under noninvasive 
ventilation (1, 40-45). The most common reasons for failure are lack of  improvement 
of alveolar hypoventilation, intolerance related to mask discomfort, a sensation of 
excessive air pressure, or claustrophobia. Uncomfortable patients become agitated 
and have difficulty coordinating their breathing with the ventilator, thus receiving 
ineffective ventilatory assistance. Failure to assist ventilation may also be caused by 
inadequate inflation pressure, nasal obstruction, or abundant tracheo-bronchial 
secretions. 
Patient-ventilator asynchrony (PVA) is the other most common reason contributing to 
NIV failure. NIV requires the patient's ventilatory drive to interact with a mechanical 
flow delivery system. If these interactions are not synchronous (i.e., if ventilatory gas 
delivery is not matched to patient demand), an increase in muscle load on respiratory 
muscles can develop (46-47). Some studies have shown that the imposed muscle load 
related to patient-ventilator asynchrony can approach or exceed the loads imposed by 
the underlying disease. Patient-ventilator asynchrony may be in the form of 
ineffective triggering (wasted inspiratory effort), also known as inspiratory-trigger 
asynchrony (48), or ineffective termination of mechanical breath (expiratory-trigger 
or cycling asynchrony)(49). Both conditions refer essentially to “phase asynchrony”; 
therefore, patient-ventilator asynchrony can be defined as a condition in which a 
mismatching between neural (patient) and mechanically (ventilator) assisted breaths 
occurs. Included in patient-ventilator asynchrony, however, is flow asynchrony, in 
which the ventilator flow delivery is inadequate to match the patient’s ventilatory 
flow demand despite a matched inspiratory time (50). The interactions between the 
patient and the ventilator are influenced by patient- and ventilator-related factors.  
3.4.1 Patient-related factors 
Respiratory center drive 
A decrease in neuromuscular drive per se may result in ineffective triggering of the 
ventilator, particularly when the set trigger variable is insufficiently sensitive.  
Respiratory (neural) timing 
The underlying mechanism of ineffective triggering efforts is the mismatching 
between patient and ventilator inspiratory time (TIneural vs TImech, respectively). 
When TIneural is longer than TImech, desynchronisation may occur, since the 
patient’s ventilatory demand has not been fully satisfied. On the other hand, when 
TIneural is shorter than TImech, ineffective efforts may develop, since the ventilator 
continues to deliver gas flow and does not cycle, encroaching on neural expiratory 
time (TEneural) and leaving less time for exhalation. The next inspiratory effort may 
thus occur at a high lung volume and be insufficient to overcome the high elastic 
recoil of the respiratory system and trigger the ventilator. Consequently, inspiratory 
effort is wasted and the ventilator fails to deliver flow. The mismatching between the 
onset of TEneural and mechanical expiratory time (TEmech) may also contribute to 
patient-ventilator asynchrony (51). 
Respiratory system mechanics 
Dynamic hyperinflation is frequently associated with ineffective triggering efforts in 
patients receiving mechanical ventilation (52). It is commonly associated with high 
ventilatory demand, high airflow resistance, or a too short expiratory time. With 
dynamic hyperinflation, the patient breathes at a high lung volume and thus with a 
high elastic recoil pressure, which is transmitted to the alveoli. The end-expiratory 
alveolar pressure is positive relative to the airway opening pressure. This positive 
pressure is termed intrinsic positive end-expiratory pressure (PEEPi). With PEEPi, the 
patient has to generate a substantial inspiratory effort to overcome the high elastic 
recoil pressure before the ventilator delivers an inspiratory flow. If the inspiratory 
effort is inadequate, the patient generates ineffective triggering efforts. Studies have 
shown that the application of external PEEP (PEEPe) titrated to static PEEPi reduced 
the frequency of ineffective triggering efforts and improved patient-ventilator 
interaction(53). Titration of PEEPe according to dynamic PEEPi (PEEPidyn) was less 
effective. This is because of the high breath-by-breath variability of PEEPidyn. The 
occurence of dynamic hyperinflation in long term NIV is classically associated with 
severe COPD, and rarely relevant for patients with OHS alone. 
3.4.2 Ventilator-related factors 
In recent years, flow triggering has become the preferred method of triggering, owing 
to a slightly faster response time and a decreased work of breathing compared with 
pressure triggering. More recently, triggering systems have been introduced that use a 
combination of flow and pressure triggering. Other ventilator related factors include 
time-cycled (i.e. :determination of a maximal duration for inspiratory pressure support) 
or flow-cycled (i.e: cycling occuring at a preset percentage of maximal inspiratory 
flow) expiratory triggering. In study by Calderini,(54) the esophagal pressure time 
product (PTPes) and the difference between patient and machine respiratory rate 
[ΔRR (p-v)] were used to evaluate the patient’s respiratory effort: Time-cycled 
expiratory triggering (such as in the VPAP® bi-level ventilator series by ResMed) 
provided a better patient-machine interaction than a flow-cycled expiratory triggering 
during NIV in the presence of air leaks. In another study by Barrera and his colleague, 
the authors demonstrated that flow triggering effectively reduces breathing effort 
when used in conjunction with a pressure-targeted ventilation mode (55). Recently, a 
unique method of triggering has been introduced by Respironics in ventilators 
intended for NIV. This technique, known as AutoTrack® sensitivity, utilizes new 
algorithms to trigger the ventilator based in measurements of airway volume and flow 
and the authors found that this method was more sensitive to patient effort than 
traditional flow triggering using the Dragger Evita 2 ventilator (56).  
3.5 Instruments to monitor NIV 
Pulse-oximetry (57) and transcutaneous carbon dioxide tension monitoring 
(capnography) (TcPCO ) (58) commonly used to monitor NIV in patients under long 
term home mechanical ventilation, allow recognition of nocturnal hypoxia and 
hypercapnia but cannot identify the precise causes of ineffective ventilatory support 
such as patient-ventilator asynchrony, periodic breathing, or central apneas (glottic 
closure). In OSAS, the sensitivity of pulse-oximetry alone for the recognition of SAS 
ranges from 40 to 100%. 
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Polysomnography (PSG) is the “gold standard” for the diagnosis of respiratory 
abnormalities during sleep and it is useful for detecting and classifying sleep apnea 
and associated disorders, but it is expensive, time-consuming, and unavailable to 
patients living far from the sleep laboratory; in addition, some patients cannot tolerate 
repeated polysomnography studies, especially elderly subjects. These limitations have 
led to diagnostic strategies of nocturnal respiratory disturbances including simple and 
portable recording devices of nocturnal breathing (polygraphy). 
Recently, an unattended device for cardio-respiratory monitoring (Poly-MESAM 
(PM),MAP; Martinsried, Germany) has been validated in adults with suspected 
OSAS, and showed a good sensitivity and specificity, compared to PSG at different 
event threshold values (59). The operation of the Poly-MESAM system is simple; in 
the first prospective study validating the method of ambulatory polysomnography 
using the Poly-MESAM, the authors demonstrated that an average of 22 minutes was 
required for a physician to attach and detach the unit; manual scoring time averaged 
9.3±6.1 minutes for the 104 patients, with a range of 2 to 29 minutes. The large 
differences result from the differences in patient scores for ODI and AHI: the more 
events requiring manual scoring, the longer the overall time required. Acceptance of 
the Poly-MESAM was rather high because of the freedom of movement and 
unrestricted driving ability of patients.  
3.6 The aims of this study were: 
We performed a study on patients with OHS under NIV with the following aims: 
1) to analyze the contribution of polygraphy and polysomnograpy to the 
detection of respiratory events such as periodic breathing, or patient-ventilator 
desynchronisation, which are not necessarily associated with a decrease in 
SaO  or an increase in TcPCO ; 2 2
2) to assess the frequency of occurrence of respiratory events and their 
association with sleep stage;  
3) to describe the efficacy of NIV (correction of nocturnal hypoventilation) and 
the sleep quality in OHS patients on long term nocturnal NPPV, in a stable 
clinical situation;  
4) to analyze the association between respiratory events, arousals from sleep, 
oxygen desaturation and nocturnal hypercapnia. 
5) to assess the validity of polygraphy as a method to estimate efficacy of NIV in 
obesity –hypoventilation syndrome. 
4. Patients and Methods  
4.1 Study population 
In a prospective study design, 20 patients with obesity-alveolar hypoventilation (OHS) 
(defined as BMI ≥ 30kg/m  and diurnal PaCO  ≥ 45 mmHg) were recruited. Patients 
were selected from all patients under NIV treated by the Division of Pulmonary 
Diseases of Geneva University Hospital.  
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Inclusion criteria were: stable clinical condition; home treatment with NIV (bi-level 
pressure support ventilators only) for at least 3 months; NIV initiated after at least one 
episodic of acute hypercapnic respiratory failure; indication for NIV accepted by the 
group of experts of the Swiss Respiratory Society (Société Suisse de Pneumologie).  
Exclusion criteria were: association with chronic obstructive pulmonary disease 
(COPD), decompensated cor pulmonale and any other unstable respiratory condition, 
comorbidities such as: neuromuscular diseases, severe hepatic failure, severe renal 
failure, severe cardiac failure, cognitive and/or sensory impairment, poor compliance 
(defined as a daily use of ventilator of less than 4h).  
The study protocol was approved by the Ethics Committee of the University Hospital 
of Geneva and written informed consent was obtained from all participants. 
4.2 Polysomnography 
Standard polysomnographic recordings were performed with an Edit-sleep apparatus 
(MAP, Martinsried, Germany) at the Sleep Laboratory of Geneva University Hospital. 
Full polysomnorgaphic and polygraphy recordings were carried out between 22:00 
hrs and 6:00 hrs. Sleep stage was determined from seven channels of 
electroencephalogram (EEG), two channels of electrooculogram (EOG: left outer 
canthus/right outer canthus), and one channel of  submental electromyogram (EMG). 
Respiratory variables were monitored using abdominal and thoracic impedance bands 
for chest wall movement. Oxyhemoglobin saturation was measured with a finger 
probe at a rate of one sample per second. Resting awake value of SpO  was noted, and 
oxyhemoglobin saturation recording continuously overnight. Positive pressure level 
was continuously measured at the mask and recorded. Noteworthy is the fact that 
polysomnography, used in this study in its’ “default configuration” did not include a 
pneumo-tachograph. Flow was derived from the pressure signal measured at the nasal 
mask. Sleep was hand scored in 30 second epochs according to the criteria of 
Rechtschaffen and Kales (60). To facilitate analysis, sleep stages 3 and 4 were 
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combined, and coded as slow wave sleep (SWS). Sleep stages were expressed as a 
percentage of total sleep time (TST). Sleep efficiency was defined as the percentage 
of the total recording time that was scored as sleep. Sleep latency was defined as the 
time from the start of the study (lights off) to sleep onset. A transient desaturation was 
defined as a decrease in SaO , of 4% or more lasting at least 10 seconds before 
returning to baseline. Arousals were defined as epochs lasting between 1.5 and 10 sec 
(61). Awakenings were defined as epochs of more than 10 sec. The mean oxygen 
saturation and the lowest oxygen desaturation were determined.  
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4.3 Poly-MESAM 
The Poly-MESAM® (MAP; Martinsried, Germany) is a small device (4.5× 19 × 13.5 
cm), battery-powered, weighing about 800 grams. In its standard version the device 
includes seven channels: (1) a flow sensor for simultaneous recording of nasal breath 
flow and snoring; (2) a three-channel ECG; (3) two stress-sensitive belts for thorax 
and abdomen effort (4); (5) a position sensor for determination of body position and 
(6) a pulse oximeter with a finger probe for measuring arterial oxygen saturation 
(SaO ). In this study, a pneumo-tachograph –which is standard equipment for this 
polygraph when monitoring CPAP– was used for all recordings, and inserted either 
between the mask and the expiratory valve, or proximally to the expiratory valve. A 
pressure transducer was also connected to the patient’s mask. The polygraph thus 
generated a “sound tracing”, recording in fact low frequency sounds such as snoring, 
major leaks, or sometimes, noises generated by the machine, a flow and a pressure 
tracing, a continuous recording of thoracic and abdominal movements, a tracing of 
pulse rate and SaO , as well as body position (lateral left or right, dorsal or ventral 
decubitus). A computer based analysis automatically calculates apnea, hypopnea, and 
desaturation events, and an index of each variable per hour of recording time, based 
on an (adjustable) default definition of each variable. Bedside graphic monitoring of 
the data, and evaluation of the raw data is also possible. The software provides the 
option of manual or automatic scoring of the pre-defined breathing events and oxygen 
desaturations. In this study, all events were either scored or checked manually (62-64). 
Respiratory events defined in the present study were scored manually; number of 
events and total time of occurrence of a pre-defined event could thus be calculated, by 
transferring the raw data to an Excel chart. 
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4.4 TcPCO2
The change in TcPCO  whilst receiving nocturnal ventilatory support was analysed. 2
Transcutaneous measurements of carbon dioxide (TcPCO ) were performed using a 
Radiometer Tina TCM3 capnograph (Radiometer®, Copenhagen, Denmark) with a 
combined TcPO  (type Clark)/tcPCO  (type Stowe-Severinghaus) electrode (model 
E5280). The calibration of the electrode was performed before each new 
measurement, with a standard (5% CO , 20.9% O ) calibration gas. To ensure optimal 
performance, the membrane of the electrode was changed for each recording. The 
electrode was positioned on the anterior chest wall, as suggested by the manufacturer, 
after thoroughly cleansing the skin with alcohol. Care was taken to avoid bony 
prominences, visible veins or any other interference with skin perfusion. The 
temperature of the electrode was set at 43 °C: this creates a local hyperaemia which 
improves the permeability of the skin to gas diffusion, and 'arterializes' the capillary 
blood to obtain TcPCO  readings closer to PaCO  values, without inducing total skin 
reactions or skin burns. This temperature is lower than the recommended 44-45°C. 
The manufacturer suggests changing the site of the electrode every 4h (and 
recalibrating). However, patient tolerance to 8 hrs of continuous monitoring (i.e. 
without changing the position of the probe) with the same electrode and capnograph 
at 43°C, has been reported.  
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4.5 Bilevel ventilation implementation 
Eleven patients were ventilated using a VPAP®II-S/T bi-level pressure support 
ventilator (ResMed, Australia). It is a portable bi-level pressure device with a turbine-
type blower capable of delivering a high inspiratory flow rate. Spontaneous, timed 
and S/T modes are available. The rise time is adjustable over a range of 0.15 –0.9 s. In 
S/T mode a minimum respiratory rate (RR) is selected. In the S/T mode, a minimal 
respiratory frequency is preset, and timed breaths are delivered if the patient’s RR 
falls below this preset value. Transition between IPAP and EPAP are triggered by the 
patients` breathing according to unadjustable flow criteria (built-in software), but a 
minimum and maximum TI (inspiratory time) can be predefined. Four patients were 
ventilated using a BiPAP®-S/T, (Respironics USA). This device may also be operated 
in spontaneous, timed or S/T model. The inspiratory time and expiratory time (TE) 
are not preselected, but are subsequently determined according to automated flow 
criteria. Four patients used a Synchrony® ventilator (Respironics USA) which can 
also can be set in a spontaneous, timed or S/T mode. As previously mentioned, the 
Synchrony ventilators uses a built-in software (Auto-Track® system) to permanently 
adjust patient-ventilator synchronization. They also have a high pressurisation 
capacity (65). IPAP values range from 5 to 30 cm H O. One patient used a Moritz S/T 2
ventilator (MAP, Germany), which features adjustable inspiratory trigger, S, S/T and 
T modes, and a maximal IPAP of 20 cm H O. 2
4.6 Study design 
 In order to study a population as homogeneous as possible, we chose patients in a 
stable clinic condition, all suffering from OHS, and treated with the same type of 
pressure support device. All patients had a run-in period of NIV of at least 3 months at 
home and a daily use of more than 4h per night, and were thus familiarized with NIV. 
Patients followed in our area undergo yearly elective evaluations of their ventilation, 
including pulse-oximetry, and nocturnal capnography: the present study was proposed 
to the patients as an alternative to their usual over-night evaluations. None of these 
patients were studied because of aggravation of their respiratory condition. After 
recruitment, and informed consent, all patients slept in the laboratory under NIV with 
simultaneous recording of polysomnography, Poly-MESAM® and trans-cutaneous 
capnography (TcPCO  Radiometer Tina TCM3®, Denmark) on a single night. During 
the study night, ventilatory assistance was provided through a nasal (n=17) or facial 
(n=3) mask, and mask flow, and pressure were recorded. Airflow was measured with 
a pneumotachograph positioned between the valve of the ventilator circuit and the 
mask. Patients were admitted to the sleep laboratory at 3:00 PM, and the sensors of 
both recording systems were attached by the technicians. The next morning, patients 
were disconnected from the machines and were discharged. As previously mentioned, 
for both PSG and PG units, only manual scoring was considered for description of 
events.  
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4.7 Measures of sleep disturbance 
4.7.1 Respiratory parameters 
4.7.1.1 Respiratory disturbance index 
The respiratory disturbance index (RDI) is the sum of the number of apneas and 
hypopneas per hour of sleep. An apnea is a complete or near complete cessation of 
airflow. Apneas were identified in cases in which respiratory flow was reduced to < 
20% of the normal level for ≥10 s. Hypopnea was defined as a reduction in amplitude 
of airflow of ≥ 50% for ≥ 10 s with a ≥ 3% drop in oxygen saturation from the 
preceeding stable SaO . The mean duration of apneas and hypopneas were calculated 
for each patients. 
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4.7.1.2 Obstructive apnea index, central apnea index or mixed index 
Apnea were defined as being central , obstructive or mixed.  
A central apnea was defined as an apnea accompanied by an absence of  thoraco-
abdominal wall movements.  
An obstructive apnea was defined as an apnea with continuing thoraco-abdominal 
wall movements.  
A mixed apnea was defined as an apnea with both central and obstructive components, 
and a central component lasting at least 5 sec.  
4.7.1.3 Periodic breathing 
Periodic breathing (PB) is characterized by recurrent central apneas or hypopneas 
during sleep alternating with a crescendo-decrescendo pattern of tidal volume. It was 
recorded if lasting > 10s. The total number of periodic breathing episodes, the 
percentage of total sleep time during which PB occurred and the sleep stage during 
which each event occurred were recorded. Analysis was derived from the thoraco-
abdominal wall movement tracings. For PSG tracings, a PB index was computed 
recording the number of central apnea or hypopnea per hour.  
Whether PB is to be considered as a consequence of patient-ventilator interaction or 
not is unclear. One of the hypotheses in the present study was that PB breathing 
would occur more frequently in patients in whom NIV induced nocturnal hypocapnia 
(results presented in Table 11). Another hypothesis is that PB is induced by higher 
flow rates related to higher levels of pressure support (Table 1). 
4.7.1.4 Percent sleep time <90% O  saturation (T < 90% Sa), mean and nadir O  
saturation 
2 2
The percent of total sleep time < 90% O  saturation, the mean and nadir (minimal) O  
saturation were also recorded.  
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4.7.1.5 TcPCO2
TcPCO  values were downloaded (as a “txt” file) from the Tina TCM3 capnograph 
and analysed using a specially configured Excel table: mean, median, maximal and 
minimal TcPCO  values were thus available as well as a graph of TcPCO  values over 
time. However, TcPCO  recordings are known to have a lag-time of approximately 5 
2
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min, thus precluding the analysis of changes in TcPCO  in short nocturnal respiratory 
events. 
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4.7.2 Sleep architecture 
The percent of total sleep time spent in stage 1-2, stages 3-4 (slow wave sleep), and in 
rapid eye movement (REM) sleep was scored according to standard criteria (60). 
Arousals, arousals index (arousals per hour), sleep efficiency (SE), total sleep time 
(TST), sleep latency, wake after sleep onset (WASO) were also computed. 
4.7.3 Patient-ventilator interaction 
4.7.3.1 Desynchronisation  
Desynchronisation was identified by observing uncoupling of the patient′s respiratory 
efforts and ontset of ventilator pressure support. The ventilator rhythm was derived 
from the flow and pressure curves (pneumotachograph integrated in the PolyMesam 
PG; pressure curve only for the PSG recording). The patient′s respiratory effort was 
derived from the thoraco-abdominal wall movements. The number of events and their 
length were recorded. The percentage of total recording time or total sleep time spent 
with patient-ventilator asynchrony was computed for each case, and the sleep stage 
during which each event occurred was recorded (Figure 3-5). 
4.7.3.2 Pressure drop 
On the polygraphy tracings, inspiratory pressure drops of more than 20% of initial 
IPAP setting were recorded and considered to be indicative of major leaks. As for the 
other events, the number of events, and the ratio of their total length to the total time 
of recording was calculated (Figure 8). 
4.7.3.3 Auto-triggering 
Auto-triggering was defined as the occurrence of a rapid succession of pressurisations 
(at least 3 events), at a respiratory rate above 40/min, and clearly above that of the 
patient’s respiratory rate. This type of event is suggestive of either a defect in 
inspiratory effort sensing by the machine, or an overly sensitive inspiratory trigger. 
Important leaks around the interface or through the mouth may contribute to poor 
sensing and trigger these events. The number of events, and the ratio of their total 
length to the total time of recording was calculated. Auto-triggering was scored 
separately but included in the total time of patient-ventilator asynchrony (Figure 9). 
4.7.3.4 Air leakage  
Air leakage was suggested by the simultaneous occurrence of a drop in inspiratory 
pressure, a decrease in abdominal and/or thoracic movements, and a “square” wave 
form of the inspiratory flow curve, lasting as long as the preset TImax. The total 
number of events and the percentage of total sleep time were recorded (Figure 10). 
4.7.3.5. Unrewarded inspiratory efforts. 
Unrewarded respiratory efforts were defined as the intermittent occurrence of 
inspiratory efforts without pressurisation by the ventilator, during less than 3 
consecutive breaths or 10 seconds, associated with synchronized supported 
respirations (Figure 4). 
5. Statistical analysis:  
Descriptive data are expressed as mean (standard deviation, ) or as median with 
range when appropriate (skewed distribution). Wilcoxon's signed-rank 
test (nonparametric) was used when appropriate to compare paired samples. Unpaired 
Student's t test were also used when appropriate (parametric data) to compare means 
and standard deviations between groups. Pearson's test was used to assess correlation 
coefficients between continuous variables. The Statistical Package for the Social 
Sciences (SPSS, version 9.0, for Windows) was used for the analysis of data. For all 
tests, a value of p < 0.05 was considered to significant. 
6. Results 
6.1 Patients 
Between August 1, 2003 and April 15, 2004, 20 patients with OHS receiving home 
NPPV therapy (8 women, 12 men, averaging 64 years of age) were enrolled in the 
study. All patients were markedly obese (body mass index [BMI], 43 ± 7 kg/m2) 
without evidence of airway obstruction. All patients completed the study and tolerated 
the experimental procedure well. Four types of bi-level pressure-cycled ventilators 
were used: the VPAP® II ST and III ST (ResMed), the Synchrony® (Respironics), 
The Moritz II® ventilator (MAP, Germany) and the BiPAP® ST (Respironics). 
Ventilators were all set in the spontaneous plus timed (S/T) mode; expiratory positive 
airway pressure (EPAP) ranged from 4 to 8 cmH O, inspiratory positive airway 
pressure (IPAP) was from 10 to 28 cmH O,
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2  and back-up respiratory rate from 10 to 
18 per minute. Four patients were receiving supplemental oxygen therapy. No patients 
received sedatives or hypnotics. The patients’ characteristics and baseline ventilator 
settings are shown in Table1.  
6.2 Sleep data 
Sleep architecture was disrupted in most patients with an increased percentage of 
stage 1 sleep (mean ± SD: 15.3 ± 5.8%), an increased arousal index (mean ± SD: 25.8 
± 8.9 n/H) and percentage of wake after sleep onset (WASO) (mean ± SD: 27.0 ± 
10.6%). A decrease in the percentage of rapid eye movement (REM) sleep (mean ± 
SD: 14.3 ± 6.1%) (Table 2) and a decreased sleep efficiency (mean ± SD: 71.3 ± 9.8%) 
(Table 2) were also observed. Arousals mostly occurred in light sleep, more than 90% 
of arousals occurring in stage 1 and 2 sleep (Table 3). Sleep efficiency and 
distribution of sleep stages varied markedly between patients; for example, patient 13 
did not demonstrate any sleep disruption (sleep stage distribution was within normal 
ranges), whereas patients 14 showed severe sleep disruption (stage1 sleep: 13.9%, 
stage 2 sleep: 76.1%, slow wave sleep: 3.2%; REM sleep: 6.7%; and 247  arousals) 
(Tables 2 and 3). 
6.3 Apnea and hypopneas 
The evaluation of data analyzed by polysomnography showed that AHI under NIV 
varied markedly among patients, with a range between 0 and 16 (mean ± SD, 5.2 ± 
5.0 n/hour ) (Table 2). Four patients still had an AHI > 10/h under BiPAP. In one case, 
episodes of hypopnea were related to repeated episodes of auto-triggering of 
ventilator, which were not perceived or described by the patient. One case showed a 
clear predominance of obstructive hypopneas, and three had obstructive and central 
hypopneas.  
6.4 TcPCO , and  O  Saturation 2 2
In spite of the fact that apnea and hypopnea were uncommon, O  desaturations were 
relatively frequent in study patients (ODI from PSG: 6.6 ± 6.4 /hour, range: 0-20.2). 
As shown in Table 1, 7 patients showed an average nocturnal SaO  below 90%. The 
mean nadir SaO  was  80 ± 7% (range: 68-91%) and mean SaO  was 91 ± 3% (range: 
85-95%). Four patients received supplemental oxygen therapy; 2 of these patients had 
severe O  desaturations despite O  supplementation: average nocturnal SaO and 
minimal SaO for them were respectively 89% and 75%; 89% and 74%. Mean 
TcPCO  also varied greatly; the mean TcPCO  was 43 ± 6 mmHg (range: 36.5-54.9 
mmHg). We did not find any significant relationship between average SaO  or nadir 
SaO  and TcPCO  (r = - 0.004 and 0.007; p = 0.986, 0.977; Spearman’s correlation) 
which suggests that in most cases hypoxaemia was not related to persisting alveolar 
hypoventilation, but rather to ventilation/perfusion mismatch  . 
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6.5 Patient-Ventilator Asynchrony 
Data from the polysomnography showed that eleven patients (55%) exhibited 
desynchronisation with their ventilator: average sleep time with patient-ventilator 
desynchronisation was 30.8 ± 23.9% of total sleep time (range: 2.8-72.6% of total 
sleep time) which was consistent with the findings from the Poly-MESAM® 
polygraph (mean ± SD: 28.2 ± 22.4%, range: 3.7-75.5%). (Table 4) The coefficient of 
correlation was 0.838 (p = 0.001)(Figure 1).  
Time spent with patient-ventilator desynchronisation as a function of sleep stage is 
shown in Table 5. The association between desynchronisation and sleep stage varied 
substantially between patients. Average percentage of time spent with patient-
ventilator asynchrony was 29.2% for stages 1-2 sleep, 38.8% for stages 3-4 and 
38.5% for REM sleep; conversely 58.2% of total patient-ventilator asynchrony 
occurred during stages 1-2 sleep, 22.2% during stages 3-4 sleep and 19.6% during 
REM sleep (Table 5).  
Despite the occurrence of patient-ventilator desynchronisation for a substantial 
proportion of total sleep time, O  desaturations were infrequent in these patients. 
When comparing patients with or without patient-ventilator desynchronisation, we did 
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not find any statistically significant difference in terms of average nocturnal SaO , 
nadir SaO or ODI. Tc
2
2 PCO  was also 2 practically identical for the two groups: indeed 
patient-ventilator desynchronisation in this group of patients did not seem to have a 
deleterious impact on these parameters (Table 6). Although alveolar ventilation 
seemed little affected by patient-ventilator asynchrony, patients who desynchronize 
with the machine had poor sleep quality, had more stage 1 and 2 sleep, more arousals, 
less slow wave and REM sleep when compared to the patients without PVA (Table 6). 
The periods of desynchronisation, varying from 10 sec to several minutes in length, 
were frequently associated with arousals. Desynchronisation-related arousals mostly 
occurred in stages 1 and 2 (68%)(Table 7). In contrast, few arousals occurred during 
desynchronisation periods in slow-wave and REM sleep (Tables 5 and 7). 
Poly-MESAM® tracings demonstrating breathing patterns without desynchronisation 
are shown in Figure 2. Figures 3-5 show different patterns of patient-ventilator 
asynchrony. Figure 3 shows a persistent delay between the initiation and the 
termination of a patient's inspiratory effort, but the respiratory frequency of patient 
and machine are identical. Figure 4 shows sustained severe desynchronisation. The 
patients' respiratory rate is high, (24 breaths per min), however, only every second 
inspiratory effort made by the patient is supported by the ventilator (repeated 
unrewarded inspiratory efforts). In figure 5, the ventilator is unable to detect most 
inspiratory efforts by the patient, the patients′ respiratory rate is higher than that of the 
ventilator.  
6.6 Periodic Breathing 
Both Poly-MESAM® and polysomnography detected a large proportion of OHS 
patients experiencing central events. Figure 6 shows periodic breathing on a Poly-
MESAM® tracing. Evaluation of data analyzed by polysomnography showed that for 
40% (n = 8) of OHS patients, the periodic breathing index ( PBI, PB numbers per 
hour) was above 5n/hour, (mean ± SD: 10.0 ± 4.8n/hour, from 5.0 to 20.5), the mean 
percent of total sleep time with  PB was 6.3 ± 4.4% (range: 1.5 to 16.2% of total sleep 
time) consistent with the findings from Poly-MESAM® (mean ± SD: 7.8 ± 7.6%, 
range:0 - 21.3%). Among the 8 patients with PB, 3 patients showed a PBI above 
10/hour (Table 8). In contrast to the distribution of patient-ventilator 
desynchronisation across all sleep stages, about 81% of periodic breathing occurred 
during stage 1 and 2 sleep (Table 9).  
Unlike the previously mentioned association between patient-ventilator 
desynchronisation and arousals in stage 1 and 2 sleep, we did not find any association 
between periodic breathing episodes and arousals: only 22.5% of periodic breathing 
events could be associated with arousals (Table 10). 
Table 11 shows mean SaO  saturation, mean and median transcutaneous CO  
(TcPCO ) according to the presence or not of periodic breathing. Surprisingly, 
occurrence of PB was not associated with a lower TcPCO ; there was no difference 
between the two groups in terms of mean and median TcPCO . We only noted a non-
significant trend for more severe desaturations in subjects with PB: when compared to 
the patients without PB, they had a lower nadir SaO  (76.4 vs. 82.3, P = 0.04) and a 
higher ODI (10.8 vs. 3.8, P = 0.01). 
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We could not substantiate the hypothesis that PB was related to higher flow rates 
related to higher pressure settings on the ventilator: IPAP and EPAP values did not 
differ significantly between patients with and without PB (unpaired t tests, p = 0.29, 
1.00 each, data not shown). The effective flow rates however were not measured, 
since the pneumo-tachograph of the Poly-MESAM® device is not calibrated for 
precise quantitative determination of flow. 
The coefficient of correlation for the detection of PB between PG and PSG results as 
a % of TST was 0.905 (P = 0.002)(Figure 7).   
6.7 Air leakage 
We hypothesized that air leaking through the mouth would be detected by the 
appearance of sustained high inspiratory flow rates with a “square wave” pattern 
characteristic of leak compensation by the BiPAP in the S/T mode, associated with a 
pressure drop and a decrease in thoraco-abdominal movements. This association of 
indices proved however difficult to detect. Although Poly-MESAM tracings 
demonstrated in several patients periods of IPAP pressure drop exceeding 20% of 
initial IPAP value (see below), this clearly underestimated the occurrence of air 
leakage. During periods of patient-ventilator asynchrony, prolonged inspiratory 
ventilator pressure waves did however frequently suggest leaks through the mouth. In 
this aspect, quantification and precise timing of air leaks by polygraphy or 
polysomnography appears less performant than leak quantification by built-in 
ventilator pneumo-tachographs, such as those available in the VPAP® ST II and III 
ventilators – with specific software for analysis.  
6.8 Inspiratory Pressure drop 
Inspiratory pressure drop was detected in 8 patients by PM (mean ± SD: 54 ± 64 min, 
lasting from 2.2 to 133 minutes; on average 11.2 ± 13% of total analyzed time, range: 
0.4 - 33.7%). Among them, 3 patients had prolonged inspiratory pressure drops 
(defined as more than 10% of total analyzed time): all of these events were associated 
with patient-ventilator asynchrony.  
6.9 Auto-triggering 
Although most of the patients presented a few episodes of auto-triggering during their 
sleep, these were too short to be relevant and could be ignored, except for one patient. 
For that patient, the auto-triggering was impressive (10.6% of TST), 72% of auto-
triggering occurred in stage 1 and 2 sleep, 23% in stage 3-4 and 5% in REM sleep. 
This patient had the highest indices of apnea and hypopnea (AHI was 16.1 per hour), 
frequent desaturations  (ODI was 14.3 per hour) and sleep efficiency was only 69%.  
7. Discussion 
This is to our knowledge the first study of sleep structure and nocturnal respiratory 
events in a large group of patients with obesity-hypoventilation syndrome treated on a 
long term basis by nocturnal non-invasive ventilation with a bi-level pressure cycled 
ventilator. All patients had been put under NIV after at least one episode of major 
hypercapnic respiratory failure, and were , at the time of the present study, in a stable 
clinical condition. Adjustment of ventilator parameters had been performed to obtain 
maximal improvement of daytime arterial blood gases, nocturnal SaO2, and TcPCO2; 
furthermore, in patients with known OSAS, EPAP values were adjusted to treat upper 
airway obstruction. The present study shows that, in terms of correction of nocturnal 
hypoventilation, results in most patients are acceptable for nocturnal SaO2 (91 ± 3%), 
nocturnal TcPCO2 (43 ± 6 mmHg), apnea, hypopnea, or apnea-hypopnea index. The 
most interesting finding of this study was that other respiratory disturbances could 
occur in patients under NIV not necessarily associated with desaturations or increases 
in TcPCO2. Among these events, the most frequently detected are intermittent or 
persistent patient-ventilator asynchrony, ventilator induced periodic breathing or 
central apneas, and auto-triggering of ventilator. Mouth leaks, although most certainly 
frequent in these patients, are underestimated by the methods used in our polygraphic 
and polysomnographic evaluation. The major adverse consequence of these events is 
sleep fragmentation, as demonstrated by the relatively poor sleep quality in patients 
studied with marked increased in percentage stage 1 and 2 sleep, reduction in 
percentages of REM sleep, and by the close association between episodes of patient-
ventilator asynchrony and arousals in stage 1 and 2. Interestingly, although the ratio 
of time spent with patient-ventilator asynchrony to total time spent in various sleep 
stages was higher for slow-wave and REM sleep than during lighter sleep stages, 
patient-ventilator asynchrony episodes  rarely caused arousals in slow-wave or REM 
sleep.  
Compared to polysomnography, results of polygraphy showed a high degree of 
correlation for detecting these respiratory events.  
7.1 Patient-ventilator asynchrony 
In acute-care settings, patient-ventilator asynchrony may contribute to failure of NIV. 
Lofaso et al (66) suggested that some failures of non-invasive ventilation could be 
ascribed to the technical characteristics of the ventilator rather than to a clinical 
condition refractory to this technique. Nava et al (67) and Goulet et al (68) stressed 
the importance of the "trigger variable" in reducing the inspiratory effort and patient-
ventilator mismatching. Patient-ventilator desynchronisation is a pervasive problem 
in NIV that has been investigated in several studies. Calderini and colleagues (69) 
demonstrated marked asynchrony when NPPV was used in the pressure support (PS) 
mode, particularly during air leaking. Meyer and colleagues (70) observed a similar 
phenomenon in which the ventilator failed to sense inspiratory effort or the onset of 
expiration during air leakage. Mouth leaks per se, probably the major contributor to 
patient-ventilator asynchrony, have been shown to increase nocturnal PtcCO  and 
decrease slow wave sleep and REM sleep (71).  
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The theoretical advantages of NIV are that it can decrease work of breathing and thus 
metabolic demand, contribute to re-setting of central chemoreceptors to a lower 
PaCO  level, open atelectatic airways, and improve ventilation/perfusion matching. 
Ideally, the ventilator should provide pressure support in the airways during the entire 
inspiratory effort, and cycle on completion of the patients' inspiratory effort (“neural 
inspiratory time”). In practice, however, in the S/T mode, there can be a variable 
delay between the initiation and/or the termination of a patient's inspiratory effort and 
the ventilator-driven pressure support wave, as shown in Figure 3. The delay between 
the initiation of the patients' inspiratory effort and the onset of pressure support is 
called inspiratory response delay: i.e. the sum of the time that the patient needs to 
decrease airway pressure below the trigger threshold and the ventilator's response 
delay. The ventilator trigger delay for bi-level pressure-cycled ventilators currently 
used in our area has been recently measured on a bench-test study and ranges from 77 
to 170 ms for the ventilators used in this study (65). The delay between the end of the 
patient's inspiratory effort and termination of pressure support is called expiratory 
response delay, and arises mainly from the arbitrariness of the inspiratory termination 
criterion. During inspiratory response delay, the patient's inspiratory effort is not 
supported by the ventilator (“unrewarded inspiratory efforts”), and during expiratory 
response (or cycling) delay, the patient is unable to exhale or must exhale against the 
IPAP pressure. Bench-testing measurements suggest that in predominantly restrictive 
pulmonary mechanics, most bi-level ventilators tend to cycle prematurely and thus 
decrease effective inspiratory pressure support (65). If however the response delay 
exceeds a critical value, the ventilator is unable to detect the following inspiratory 
effort by the patient, and thus desynchronisation between patient and ventilator occurs. 
Figure 4 illustrates such a type of desynchronisation.  
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Patient-ventilator asynchrony is probably common in NIV and may contribute to a 
lesser correction of alveolar hypoventilation, or to a degradation of sleep architecture. 
It seems thus necessary not only to monitor endpoints of NIV such as nocturnal SaO  
or TcPCO  and daytime blood gases, but also to monitor patient-ventilator 
asynchrony because of its’ deleterious impact on sleep quality and thus on quality of 
life and daytime symptoms. To our knowledge, the present study is the first study to 
demonstrate the effect of patient-ventilator asynchrony on sleep quality in a 
homogeneous group of patients with OHS treated by home NIV, and to show that 
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occurrence of patient-ventilator asynchrony is very common: indeed, eleven patients 
(55%) exhibited desynchronisation in the present study. Desynchronisation was 
associated with multiple arousals during stages 1-2 sleep; interestingly 68% of 
arousals occurred at the end of a period of desynchronisation, and where thus most 
probably caused by the desychronisation; also, the arousals often terminated the event, 
and were followed by a synchronized patient-ventilator breathing. It can also reduce 
the amount the REM sleep and increase stage 1 sleep. 
In 4 of the 11 patients with repeated episodes of desynchronisation, 
desynchronisation was severe, i.e. more than 40% of the total sleep time was spent in 
asynchrony with the ventilator. Thus, moderate or severe desynchronisation seems to 
be a frequent event in patients with OHS, in a stable condition, ventilated on a long 
term basis, and subjectively well adapted and compliant to their treatment.  
Most of the patient-ventilator asynchrony during stage 1 and stage 2 was associated 
with arousals; the mechanisms by which patient-ventilator asynchrony might have 
contributed to arousals can not be ascertained from our study, but oxygen 
desaturations were seldom associated with the arousals. Although the lag time of 
TpcCO2 recordings (several minutes) precludes identification of rapid changes in 
PaCO2, prolonged desynchronisations were not associated with an increase in TcPCO2. 
This indicates that other factors must be responsible for arousals induced during the 
patient-ventilator desynchronisation. Air leakage may have contributed to arousals 
and sleep disruption (71), but as previously mentioned, PG and PSG were in fact poor 
detectors of air leaks. Simultaneous recording of leaks by built-in software and 
pneumotachograph on certain ventilators may prove helpful in understanding the 
relationship between major leaks, patient ventilator-asynchrony, and arousals. Such a 
software was not available at the time this study was designed and started; 
furthermore, only one of the ventilators used in this study is at present provided with 
such a possibility (VPAP III S/T® by ResMed). 
Although patient-ventilator asynchrony appeared to contribute to frequent arousals 
during stages 1-2 sleep, this was not the case during slow-wave and REM sleep. 
Arousals occurred with the lowest frequency during slow-wave and REM sleep 
despite an average of 38.5 – 38.8% of time spent with patient-ventilator asynchrony. 
Our interpretation is that the threshold for arousal increases during slow-wave sleep, 
rendering arousal infrequent. Others (72) have noted increases in arousal threshold for 
hypercapnia during slow-wave sleep. During lighter stages of sleep, arousals limit and 
frequently interrupt patient-ventilator asynchrony, but they fragment sleep, impeding 
and sometimes preventing entry into slow-wave and REM sleep. In the present study, 
patients who had more frequent arousals in the stage 1-2 sleep had a higher 
percentage of stage 1 sleep, and a lower percentage of REM sleep when compared to 
patients with unfrequent arousals in stage 1-2 sleep. During slow-wave and REM 
sleep, the lack of arousals allows patient-ventilator asynchrony to continue unabated.  
The sleep fragmentation that results from patient-ventilator deschronization should 
not be considered as evidence that nocturnal nasal ventilation is detrimental to sleep 
quality. Masa (73) found that sleep quality was better with nocturnal nasal ventilation 
than without it when ventilatory assistance was temporarily withdrawn from patients 
with chronic respiratory failure. Rather, these results stress the potential importance of 
an optimal adjustment of inspiratory and expiratory triggers on ventilators, when 
available. 
For most of our patients, the mean TcPCO2 and the O2 saturation under NIV were 
acceptable, although the design of this study did not offer a control night without 
ventilator. A previous study (38) evaluated the effectiveness of NIV on nocturnal 
SaO2 and PaCO2 in 11 obese patients, compared with night-time oxygen alone. The 
authors found that daytime PaO2, nighttime SaO2 and PaCO2 improved significantly 
when the patients were treated with NIV, whereas treatment with nocturnal oxygen 
only succeeded in improving nocturnal oxygenation, with a tendency to increased 
nocturnal PaCO2.  
We conclude that patient-ventilator asynchrony occurs during sleep in patients with 
OHS using nocturnal nasal ventilation. Patient-ventilator asynchrony is associated 
with arousals and thereby contributes to sleep fragmentation, decreased sleep 
efficiency, and reduced sleep quality.  
7.2 Periodic Breathing 
Eight OHS patients (40%) presented with nocturnal bouts of periodic breathing in 
the present study. Periodic breathing, with its’ recurrent periods of hyperventilation 
separated by intervals of apnea or near-apnea, has fascinated physicians for years. The 
pattern of periodic breathing can vary considerably. Cheyne-Stokes respiration is 
characterized by rhythmic rises and falls in tidal volume and breathing frequency and 
is usually observed in patients with congestive heart failure.  
At first, periodic breathing, regardless of the type, was thought to indicate a poor 
prognosis and to arise from serious neurologic or cardiovascular disease. It is now 
known that periodic breathing generally occurs during sleep, and that it may also 
occur in healthy persons (74). The mechanisms of periodic breathing have been 
studied in humans and are beyond the scope of the present study (75-77). However, 
periodic breathing or CSB is usually associated with an increased chemosensitivity of 
respiratory centers to changes in PaCO2 manifested by hyperventilation or 
hypocapnia, which were not present in our OHS patients. In the present study, we 
found that TcPCO2 was not decreased during the occurrence of periodic breathing, 
mean and median TcPCO2 in the periodic breathing group were practically identical 
to those in the non-periodic breathing group. In fact, Berger et al (78) measured acute 
kinetics of CO2 during periodic breathing in 11 obese patients with OSA during 
daytime sleep. They found that periodic breathing provided a mechanism for acute 
hypercapnia in OSA. Although hypoxia has been shown to have an important role in 
the pathogenesis of periodic breathing at high altitude, it’s role in triggering periodic 
breathing in our patients is uncertain; patients with PB had a lower nadir SaO2 and a 
higher ODI when compared to patients without PB but this was more probably the 
result of PB rather than its’ cause (77). 
As opposed to findings associated with patient-ventilator asynchrony, we found that 
in periodic breathing, arousals often occur after airflow has resumed. It therefore 
appears that resumption of airflow following periodic breathing is not always 
dependent on an arousal. Similar conclusions have been drawn in previous studies 
(77, 79, 80). Indeed, this is also the case in periodic breathing without ventilator 
support, associated either with chronic heart failure or neurological disorders. We also 
found that periodic breathing is more pronounced during stages 1 and 2 of NREM 
sleep.  
The mechanism of PB in these patients is yet undetermined: we could not 
substantiate either a relationship between PB and hypocapnia, or a relationship with 
higher IPAP pressures and thus higher ventilator-generated airflow. Transient 
ventilator-induced alterations in glottic aperture have been previoulsy reported. Kuna 
et al (81) induced an adduction of the vocal cords and a reduction in the size of the 
glottic aperture during NREM sleep in normal subjects by passively hyperventilating 
them with non-invasive volumetric ventilation. Jounieaux et al (82) described a 
progressive narrowing of the glottic aperture with increasing delivered minute 
ventilation during sleep, in normal subjects ventilated by volumetric NIV; narrowing 
of glottic width was more important during non-REM sleep than during wakefulness; 
furthermore, the glottis was significantly narrower during Stage II than during Stage 
III-IV sleep; inhaling CO2 widened the glottic aperture in some – but not all – 
subjects studied (5/9) suggesting a possible role for hypocapnia in the mechanism of 
glottic closure. More recently, however, Parreira et al (83) showed, in normal subjects 
subjected to nasal two-level positive pressure ventilation during wakefullness, that  
increasing IPAP pressures from 10 to 20 cmH2O did not induce any noticeable 
change in glottic aperture, although higher levels of IPAP increased alveolar 
ventilation. These studies raise the possibility of a relationship between ventilator-
induced hypocapnia and central apnea or hypopnea, although, to our knowledge, this 
has not been described with bi-level positive pressure ventilation. Further studies are 
needed to improve our understanding of these events. 
7.3 Polygraphy versus polysomnography 
The frequency of apnea and hypopnea was normalized for most of our patients. 
Previous studies demonstrated that the sensitivity of polygraphy vs. polysomnography 
for detecting hypopneas or apneas is between 78% and 100%, and specificity is 
between 63% and 100% (62-64, 84). In a study by Verse et al (59), using the same PG 
unit (PolyMesam), the sensitivity of PG in detecting patients with an AHI > 10 was 
92%, while the specificity was 96.3%. PG may provide an inexpensive alternative 
method for diagnosing sleep-disordered breathing. Results of the present study show 
an excellent agreement between PG and PSG for detection of periodic breathing, 
auto-triggering by the ventilator and patient-ventilator asynchrony. There were 
however slight differences in mean values between PG and PSG for the quantification 
of patient-ventilator asynchrony and PB. This may result from 1/ artifacts interfering 
with one of the tracings, which did not necessarily occur simultaneously (these 
portions were deleted from analysis); 2/ although PG and PSG were performed 
simultaneously, analysis of PG is continuous over the recording period, whereas PSG 
refers to total sleep time. 3/ Interestingly, the fact that the PG was equipped with a 
pneumo-tachograph facilitated the detailed analysis of patient-machine asynchrony, 
when compared to the PSG tracings derived from the pressure transducer. Thus PVA 
time tended to be somewhat higher on PG tracings.  
The PG device also has limitations in this setting. First, this device does not 
measure sleep, and as such the PG-determined AHI and respiratory event indices 
would tend to underestimate the polysomnography-defined indices. Secondly, we 
found that both PG and PSG are unreliable for the detection and quantification of air 
leakage. Pressure drops on the inspiratory portion of the pressure curve certainly 
suggest major leaking, but, because of the high flow rates that can be generated by bi-
level ventilators and their high pressurisation capacities, this event has a low 
sensitivity. Prolonged inspiratory pressure and flow wave (reaching values of preset 
maximal inspiratory time, or Timax), i.e. delayed cycling, may certainly occur with 
mouth leaks but may be difficult to detect because of the high variability of the flow 
and pressure wave form. Third, in nearly all studies providing evidence that a PM unit 
could be used for diagnosing OSA, analysis was either manual or a combination of 
automatic and manual; this was also the case in this study, and is a time-consuming 
process: thus careful review of raw data is mandatory (80).  
Which technique should thus be considered the gold standard for monitoring NIV in 
these patients? Our study shows that a pneumo-tachograph is contributive to an easier 
analysis of patient ventilator interactions: PG tracings (with the pneumo-tachograph) 
allowed the detection of triggering or cycling defects which were much more difficult 
to detect on PSG tracings (Figure 3).The contribution of these observations to clinical 
management should be further studied. EMG analysis of respiratory muscles was not 
possible in this study setting because of the simultaneous recording of thoracic and 
abdominal movements by PG and PSG. The potential contribution of diaphragm EMG 
should also be studied, in order to better define the relationships between TIneur and 
TImech. The obvious contribution of PSG is the analysis of the repercussion of PVA 
on sleep structure, which is the major impact of PVA. An optimal technique should 
thus offer an analysis of sleep structure, a simultaneous recording with a pneumo-
tachograph and a pressure transducer, and monitoring of leaks (available through 
built-in software incorporated in certain ventilators such as the VPAP III series). The 
drawbacks of PSG are however its’ price, its’ availability, and the necessity of in-
hospital recordings. In clinical practice, PG with a quantification of leaks would be 
sufficient. 
7.4 Study limitations 
1. Our study protocol included just one night of PSG recording: this may have over-
estimated the sleep disruption and sleep fragmentation related to adaptation to the 
instrumental set-up and complex design of the study.  
2. PSG may be useful to detect sleep disturbances related to undetectable respiratory 
events such as desynchonisation but pneumo-tachography may be necessary to 
better estimate the relationship between asynchrony and sleep fragmentation.  
3. No estimation of sleep disturbances and respiratory disorders was available before 
the beginning of NIV. This resulted from the fact that most patients were put on 
NIV after an acute episode of hypercapnic respiratory failure and were not treated 
beforehand for sleep-disordered breathing. 
4. Finally, scoring of polygraphy and polysomnography was performed manually: 
indeed, no software was available for automatic detection and quantification of 
the newly defined respiratory events. This process was quite time-consuming.  
8. Conclusions:  
The present study illustrates that in patients receiving nocturnal NIV, the occurrence 
of patient-ventilator asynchrony is very common and can have a detrimental effect on 
quality of sleep, induce multiple arousals, and reduce the amount of slow-wave and 
REM sleep. Despite patient-ventilator asynchrony, mean SaO2 and transcutaneous 
measurements of carbon dioxide (TcPCO2) were satisfactory, and were not suggestive 
of either patient-ventilator asynchrony or periodic breathing. Relying only on 
nocturnal pulse-oximetry and capnography for monitoring nocturnal NIV would thus 
underestimate the occurrence of probably relevant respiratory events. Periodic 
breathing is also common in OHS patients, most of it occurring during stage 1 or 2 
sleep; as opposed to patient-ventilator asynchrony, arousals often occur after airflow 
has resumed. Compared to polysomnography, polygraphy allowed the detection of 
these respiratory disturbances, and appears thus helpful as an adjunct to capnography 
for monitoring NIV in an ambulatory setting. When using standard PSG protocols (i.e. 
with only a pressure transducer and without a pneumotacograph), PG tracings often 
permitted a more detailed and “in depth” analysis of patient-ventilator interactions. 
Even if the major goal of nocturnal NIV is the correction of nocturnal hypoventilation, 
the detection of events which have a deleterious effect on sleep quality appears 
warranted for quality of care and patient comfort. The major drawback was the poor 
sensitivity of PSG and PG in the detection and quantification of air leaks: built-in 
software (and pneumo-tachgraph) available in some of the most recent bi-level 
pressure cycled ventilators may compensate for this limitation.  
 
 
 
 
0 10 20 30 40 50 60 70 80
0
10
20
30
40
50
60
70
80
%
 P
V
A 
po
ly
gr
ap
hy
% PVA polysomnography
 
 
 
Figure 1. Correlation between PSG and PG for the quantification of patient-ventilator 
asynchrony as a percentage of total sleep time (PSG) or total time of analysis (PG). PG and 
PSG were synchronized during analysis. The coefficient of correlation was r=0.838 (p = 
0.001) 
 
 
 
 
 
Figure 2. Polygraphy tracing  showing satisfactory patient-ventilator synchronization. Figure 
shows 1 min of recording. 1st line: breath sounds; 2nd line: flow; 3nd line: pressure wave 
(measured at the mask); 4rd line: thoracic movements; 5th line: abdominal movements; 6th line: 
ECG (signal on PSG only); 7th line: O2 saturation. 
 
 
 
 
 
Figure 3. Tracing showing one type of patient-ventilator asynchrony. Delay between the 
initiation of patient′s inspiratory effort (dotted vertical line on left) and triggering of ventilator  
with an identical respiratory frequency between patient and ventilator. Dotted vertical line on 
right shows that in most respiratory cycles, thoraco-abdominal expiratory movements and 
ventilator expiratory cycling occurred simultaneously.  2nd line: flow; 3nd line: pressure wave 
(measured at the mask); 4rd line: thoracic movements; 5th line: abdominal movements; 7th line: 
O2 saturation. Figure shows 1 min of recording. 
 
 
 
 
Figure 4. Representative tracing from a patient during patient-ventilator asynchrony. The 
patient′s respiratory rate is very high (24-28 breaths per minute); only every second 
inspiratory effort by the patient triggers the ventilator and is supported by the ventilator. Red 
arrows show unrewarded respiratory movements, i.e. without simultaneous pressurisation, 
occuring at regular intervals. 2nd line: flow; 3nd line: pressure wave (measured at the mask); 
4rd line: thoracic movements; 5th line: abdominal movements; 7th line: O2 saturation. Figure 
shows 1 min of recording.  
  
 
Figure 5. Polygraphy tracing showing sustained severe desynchronisation: the ventilator was 
unable to detect inspiratory efforts by the patient. Red arrows show unrewarded respiratory 
movements, i.e. without simultaneous pressurisation. 2nd line: flow; 3nd line: pressure wave 
(measured at the mask); 4rd line: thoracic movements; 5th line: abdominal movements; 7th line: 
O2 saturation. Figure shows 1 min of recording. 
 
 
 
 
  
Figure 6. Polygraphy showing typical periodic breathing, with slightly delayed desaturations. 
On this bout of recording, pressure was not recorded. 2nd line: flow; 4rd line: thoracic 
movements; 5th line: abdominal movements; 7th line: O2 saturation. For technical reasons 
(simultaneous PG and PSG), ECG (5th line) was coupled only to PSG tracings. Figure shows 
1 min of recording.  
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Figure 7: Correlation between PSG and PG for quantification of periodic breathings a 
percentage of total sleep time (PSG) or total time of analysis (PG). PG and PSG were 
synchronized during analysis. The coefficient of correlation for the detection of PB 
between PG and PSG results as a % of TST was r=.905 (p= 0.002)  
 
 
 
 
Figure 8. Polygraphy tracing showing inspiratory pressure drop. Pressure drop was 
considered significant when above 20% of initial IPAP value (dotted horizontal line). 
Pressure drops are most probably related to major leaks, which cannot be compensated by the 
ventilator. 2nd line: flow; 3nd line: pressure wave (measured at the mask); 4rd line: thoracic 
movements; 5th line: abdominal movements; 7th line: O2 saturation. Figure shows 1 min of 
recording.  
 
 
 
 
 
Figure 9. Polygraphy tracing illustrating auto-triggering of the ventilator. Frequency of 
ventilator is above 40/min, and totally desynchronized with inspiratory efforts. 2nd line: flow; 
3nd line: pressure wave (measured at the mask); 4rd line: thoracic movements; 5th line: 
abdominal movements; 7th line: O2 saturation. Such events were un-noticed by the patient. 
 
Figure 10. Tracing suggesting air leakage from the mouth, 2nd line: flow; note absence of 
expiratory flow curve, and flow limitation on right; 3nd line: pressure wave (measured at the 
mask): note frequent occurrence of prolonged pressurisation, probably reaching TiMAX; 4rd 
line: thoracic movements; 5th line: abdominal movements; 7th line: O2 saturation. Figure 
shows 1 min of recording. 
 
 
 
 
 

Table1. Patient characteristics, ventilator settings, O2 saturation and TcPCO2  
 
Patients Sex 
Age 
(yrs) 
BMI 
(kg/m2) BiPAP 
IPAP 
(cmH2O) 
EPAP 
(cmH2O) 
RR 
per min 
O2 
(l/min) SaO2 mean SaO2 min 
% 
86<SaO2 <90 
% 
81<SaO2 <85 
MeanTcPCO2 
(mmHg) 
MedianTcPCO2 
(mmHg) 
1 m 71 42.8 VPAPIII S/T 18 6 14 no 87 68 61.6 23.4 40.6 40.6 
2 f 63 48.5 VPAP II S/T 12 4 12 no 91 80 42.2 0.9 --  
3 m 77 34.2 Synchrony 18 6 14 no 90 80 68.9 6.8 42.2 42.5 
4 m 57 53.2 BiPAP S/T 10 6 14 no 94 84 5.2 0.2 41.6 41.6 
5 f 79 57.3 VPAP II S/T 22 7 15 1 89 75 54 5.0 49.3 49.5 
6 m 61 45.9 VPAP II S/T 22 7 15 no 91 84 79.7 4.6 39.2 40.2 
7 f 78 32.6 BiPAP S/T 18 8 12 2 93 90 1.7 0 41.0 41.2 
8 f 49 40.1 VPAP II S/T 16 6 12 no 93 80 5.7 0.1 45.1 45.2 
9 m 54 39.1 VPAP II S/T 18 5 12 no 91 78 34.3 0.3 43.9 45.2 
10 m 57 41.9 VPAP II S/T 22 7 18 no 95 82 1.3 0.1 36.5 36.2 
11 m 38 32.2 BiPAP S/T 18 6 15 no 88 68 3.3 0.9 41.9 42.2 
12 f 69 48.8 Synchrony 22 6 15 1.5 91 81 48.6 2.3 48.9 49.0 
13 f 65 47.9 VPAP II S/T 25 5 14 no 90 80 65.2 3.0 51.4 51.5 
14 f 75 35.7 VPAP II S/T 18 8 12 no 85 71 36.8 54.3 41.6 43.0 
15 m 59 41.2 VPAP II S/T 12 6 10 no 95 91 0 0 - - 
16 m 44 53.1 Synchrony 28 8 10 3 89 74 65.7 4.4 54.9 55.5 
17 m 72 38.5 Synchrony 24 8 12 no 89 83 80.2 1.9 36.6 35.2 
18 f 77 39.0 Moritz S/T 15 4 14 no 92 83 26.3 0.4 53.7 53.5 
19 m 61 45.5 BiPAP S/T 18 8 18 no 91 86 43.3 7.4 48.5 48.3 
20 m 64 39.9 VPAPIII S/T 14 4 16 no 88 75 46.1 30.9 37.1 38.0 
Mean  64 42.9  19 6 14  91 80 38.5 7.3 43 44 
SD  12 7.0  5 1 2  3 7 27.7 13.9 6 6 
 
 Table 2. Results of analysis of polysomnography of patients included in the study 
 
Patients TST 
(minutes) 
%S1 %S2 %S3-4 %Srem SL 
(minutes) 
SE 
(%) 
WASO 
(%) 
AI 
(n/H) 
HI 
(n/H) 
AHI 
(n/H) 
ODI 
(n/H) 
AI (n/H) 
1 405 15.9 53.7 13.6 16.9 2 75 24.5 0.6 2.9 3.5 10.7 17.8 
2 326 21.6 58.8 11.7 8.0 14 74 37.2 0 0.8 0.8 11.4 29.5 
3 275 12.6 45.8 28.8 12.6 20 51 46.1 0 0 0 10.9 22.5 
4 402 21.8 56.1 11.9 10.3 3 70 29.3 0 9.9 9.9 20 26.6 
5 336 16.6 63.9 7.9 11.8 17 54 44 0 0 0 0.9 47.9 
6 384 10.9 49.3 27.9 12.2 19 75 16.8 0 0.8 0.8 1.1 16.3 
7 323 20.2 39.5 28.4 12.1 4 62 36.1 0 3 3 0 25.6 
8 382 15.9 43.5 22.3 18.6 27 69 26.2 0.3 15.8 16.1 14.3 26.3 
9 362 9.6 46.2 36.7 7.7 17 67 30.9 0 2.1 2.1 6.5 28.9 
10 324 13.3 42.5 33.2 11 5 64 35 0 3.6 3.6 2.8 25.6 
11 494 11.5 63.8 13.9 10.7 17 89 10.6 2.3 8.7 11.0 8.7 31.1 
12 437 9.6 61.1 16.7 12.6 10 82 12.9 0 4.3 4.3 2.3 23.9 
13 423 11.1 38.3 24 26.7 10 76 21.4 0 4.5 4.5 2.4 10.1 
14 494 13.9 76.1 3.2 6.7 49 83 9.7 0 6.2 6.2 9.2 30.0 
15 462 15.5 57.5 6.6 20.5 9 78 21.1 0 0.5 0.5 0 31.7 
16 452 20 54.9 9.1 16.1 4 80 19.3 3 12.9 15.9 20.2 31.4 
17 347 25.9 55.8 6.5 12.0 9 58 40.2 0 5.1 5.1 0.9 35.2 
18 406 11.4 42.7 26.4 19.5 12 75 26.4 0 1.2 1.2 1.8 17.9 
19 285 18.9 52.6 18.9 9.8 6 69 28.9 0.8 4.5 5.3 1.1 29.0 
20 402 9.2 32.6 28.9 29.4 4 75 23.5 0.4 10.7 11.1 6.3 8.1 
Mean 386 15.3 51.7 18.8 14.3 12.9 71.3 27.0 0.4 4.9 5.2 6.6±6.4 25.8 
SD 64 5.8 10.5 10.0 6.1 10.9 9.8 10.6 0.8 4.5 5.0 0 8.9 
Normal values 420-480 4-7 50-55 20-25 20-25 <30 >90 5-7 <5 <5 <5 <10  
Table 3. Occurrence of micro arousals as a function of sleep stage 
 
Patients  
TA a
 
S1-2  
(minutes) 
 
% of  TST 
S1-2 
Arousalsb
 
AI c
 
%TA d
 
S3-4 
(minutes) 
 
% of  TST 
S3-4 
Arousalsb
 
AI c
 
%TA d
 
Srem 
(minutes) 
 
% of  TST 
Srem 
Arousalsb
 
AI c
 
%TA d
1 120 282 69.6 107 22.7 89.2 55 13.6 1 1.1 0.8 68 16.9 12 10.5 10 
2 159 262 80.4 145 33.2 91.2 38 11.7 4 6.3 2.5 26 8.0 10 23.1 6.3 
3 103 161 58.4 90 33.5 87.4 79 28.8 10 7.6 9.7 35 12.6 3 5.2 5.0 
4 176 313 77.9 172 33 97.7 47 11.9 2 2.5 1.1 41 10.3 2 4.4 2.5 
5 267 270 80.5 263 58.4 98.5 27 7.9 2 5.5 0.7 39 11.8 1 3 0.8 
6 104 231 60.2 101 26.2 97.1 107 27.9 0 0 0 47 12.2 3 3.9 2.9 
7 141 193 59.7 139 43.1 98.6 91 28.4 0 0 0 34 12.1 2 3.6 1.4 
8 167 227 59.5 159 42 95.2 83 22.3 1 0.7 0.4 71 18.6 7 6.8 4.4 
9 176 202 55.8 136 40.5 77.3 133 36.7 30 13.1 17.0 28 7.7 10 19.3 5.7 
10 142 181 55.8 121 40.2 85.2 107 33.2 5 2.2 3.5 36 11 16 20.2 11.5 
11 256 372 75.3 239 38.5 93.4 69 13.9 3 2.6 1.2 53 10.7 14 15.9 5.4 
12 173 309 70.7 158 30.6 91.3 73 16.7 12 9.9 6.9 55 12.6 3 4.4 2.2 
13 70 209 49.4 64 18.4 91.4 102 24 1 0.6 0.9 113 26.7 5 3.2 7.7 
14 247 445 90 241 32.5 97.6 16 3.2 1 3.8 1.5 33 6.7 5 9.0 0.9 
15 239 337 73 222 39.5 92.9 30 6.6 3 7.9 3.3 95 20.5 14 11.4 3.8 
16 236 339 74.9 220 38.9 93.2 41 9.1 4 7.9 3.3 73 16.1 12 11.4 3.5 
17 200 284 80.7 191 41.0 95.5 22 6.5 2 5.3 2.7 41 12.0 7 10.0 1.8 
18 122 220 54.1 105 28.7 86.1 107 26.4 12 6.8 5.8 79 19.5 5 3.9 8.4 
19 144 204 71.5 139 40.9 96.5 54 18.9 0 0 0 28 9.8 5 8.6 3.5 
20 44 168 41.8 40 17.5 90.9 116 28.9 0 0 0 119 29.4 4 2 9.1 
Mean 164 260 67.0 152.6 35.0 92.3 69.9 18.8 4.7 4.2 3.1 55.7 14.3 7.0 9.0 4.8 
SD 62 75 12.6 61.5 9.5 5.4 35.1 10.0 7.1 3.8 4.2 28.1 6.1 4.6 6.3 3.1 
a  total  arousals,   b  total   arousals in each sleep stage,    c    arousals index ( arousals per hour) in each sleep stage,    
 d     % percentage of total  arousals in each sleep stage
Table 4. Comparison of polygraphy and polysomnography to assess PVA 
 
 
 
TAT minutes 
Polygraphy 
PVA minutes 
 
%TAT 
 
TST minutes 
PSG 
PVA minutes 
 
%TST 
1 526 286.3 54.5 405 294 72.6 
2 488 131 26.8 326 79 24.5 
3 509 66 13.0 402 25 6.1 
4 280 16 5.7 336 36 10.7 
5 534 57.3 10.7 323 62 19.2 
6 281 99 35.2 362 52 14.2 
7 520 78 15 437 126 29 
8 538 20 3.7 494 14 2.8 
9 467 201 43 452 260 57.5 
10 527 398 75.5 347 207 59.7 
11 414 111 26.8 285 122 42.8 
 Mean±SD 462±97 133±118 28.2±22.4 379±64 116±97 30.8±23.9 
 Maximum 538 398 75.5 494 294 72.6 
Minimum 281 16 3.7 285 14 2.8 
 
Table 5. Occurrence of patient-ventilator asynchrony (PVA) according to sleep stage.  
 
Stage 1-2 sleep Stage 3-4 sleep Stage REM sleep  
Patients 
TST a 
(minutes) 
TAT b 
(minutes) 
%TST c
AT d 
(minutes) 
% S1-2 e %TAT f AT d 
(minutes) 
% S3-4 e %TAT f AT d 
(minutes) 
% Srem e %TAT f
Nadir 
SaO2
Mean 
SO2
Mean 
TcPCO2 
(mmHg) 
1 323 62 19.2 30 15.5 48.5 20 22.0 32.3 12 35.3 19.2 90 93 41.2 
2 362 52 14.1 29 14.5 55.8 22 16.5 42.3 1 3.6 1.9 78 91 43.9 
3 437 126 29 85 27.5 67.5 24 32.9 19.0 17 30.9 13.5 81 91 49 
4 494 14 2.7 0 0 0 0 0 0 14 45.5 100 71 85 41.6 
5 452 260 57.5 227 67.0 87.3 2 5.9 0.8 31 42.5 11.9 74 89 55.5 
6 347 207 59.7 165 58.1 79.7 16 72.7 7.7 26 63.5 12.6 83 89 40.7 
7 285 122 42.8 81 39.7 66.5 15 27.8 12.3 26 100 21.3 86 91 48.5 
8 336 36 10.7 22 8.5 59.0 14 59.3 41.0 0 0 0 75 89 49.5 
9 402 25 6.1 13 4.2 52.0 9 19.1 36 3 7.3 12 84 94 41.6 
10 405 294 72.6 193 69.1 65.4 54 100 18.5 47 70.6 16.1 68 87 40.6 
11 325 79 24.5 46 17.6 58.2 27 71.1 34.1 6 24.8 7.6 80 91  
Mean 379 116 30.8 81 29.2 58.2 19 38.8 22.2 17 38.5 19.6 79.1 90 45.2 
  SD 64 97 23.9 79 25.3 22.5 15 32.0 15.7 15 30.7 27.4 6.7 3 5.1 
  Maximum 494 294 72.6 227 69.1 87.3 54 100 42.3 47 100 100 90 94 55.5 
  Minimum 285 14 2.7 0 0 0 0 0 0 0 0 0 68 85 38 
 
a  total sleep time,  b  total patient-ventilator asynchrony time during sleep,  c  % percentage of time spent with patient-ventilator asynchrony during sleep,  
d  total minutes of patient-ventilator asynchrony in each sleep stage,  e  % percentage of time spent with patient-ventilator asynchrony in each sleep stage,   
f  % percentage of total asynchrony time in each sleep stage 
 
Table 6. Results of PSG in patients with or without PVA  
 
 Patients with PVA 
n=11 
Patients without PVA 
n=9 
P values 
TST(min) 379±64 395±66 NS 
%S1 17.6±5.1 12.4±2.2 0.008 
%S2 56.2±9.4 46.2±9.5 0.031 
%S34 15.0±10.0 23.6±8.4 0.050 
%Srem 11.3±3.3 17.9±6.9 0.022 
AHI (n/H) 5.1±4.5 5.4±5.9 NS 
ODI 7.6±7.5 5.4±5.0 NS 
AI  30±8 21±9 0.032 
 SaO2min 79±7 80±6 NS 
 SaO2mean 90±3 91±3 NS 
TcPCO2mean(mmHg) 45±6 43±6 NS 
TcPCO2median(mmHg) 45±6 44±6 NS 
 
 Table 7. Occurrence of arousals during patient-ventilator asynchrony according to sleep stage 
 
Stage 1-2 Stage 3-4 Stage REM  
Patients Total 
minutes a
Total 
arousals b
%asynchrony 
associated arousals c
AI d (n/H) Total 
minutes a
Total 
arousals b
%asynchrony 
associated arousals c
AI d (n/H) Total 
minutes a
Total 
arousals b
%asynchrony 
associated arousals c
AI d (n/H) 
1 193 139 67 43.1 91 0 8 0 34 0 0 3.6 
2 202 136 58 40.5 133 30 37 13.1 28 10 0 19.3 
3 309 158 55 30.6 73 12 11 9.9 55 3 33 4.4 
4 445 241 - 32.5 16 1 - 3.8 33 5 14 9.0 
5 339 220 97 38.9 41 4 0 7.9 73 12 68 11.4 
6 284 191 56 41.0 22 2 5 5.3 41 7 12 10.0 
7 204 139 82 40.9 54 0 4 0 28 5 57 8.6 
8 270 263 80 58.4 27 2 0 5.5 39 1  3 
9 313 172 33 33 47 2 50 2.5 41 2 0 4.4 
10 282 107 82 22.7 55 1 7 1.1 68 12 52 10.5 
11 262 145 62 33.2 38 4 22.7 6.3 26 10 19.1 23.1 
Mean 284 177 68 38.2 55.9 5.4 13.6 4.9 44 5.7 26.2 8.4 
  SD 76 51 19 9.5 35.5 9.3 17.6 4.4 16 4.4 27.0 5.9 
  Maximum 445 263 97 58.4 133 30 50 13.1 73 12 68 23.1 
  Minimum 193 107 33 22.7 16 0 0 0 26 0 0 3.6 
 
a  total number minutes in each sleep stage  b  total arousals in each sleep stage  c  % percentage of arousals occurring during patient-ventilator asynchrony 
d total  arousals per hour 
 
 
Table 8. Comparison of polygraphy and polysomnography to assess periodic breathing  
 
 
 
 Analyzed minutes 
Polygraphy 
PB minutes 
 
%TPT a
 
PBI b
 
TST minutes 
PSG 
PB minutes 
 
%TST c
 
PBI b
1 526 52.5 10.0 8.5 405 28.9 7.1 9.0 
2 535 18.7 3.5 5.9 275 13.4 4.9 5.0 
3 509 108.6 21.3 18.0 402 65 16.2 20.5 
4 517 85.8 16.6 10.2 494 36 7.3 11.2 
5 538 0 0 0 494 15.7 3.2 9.4 
6 532 5.5 1.0 5.0 462 7.1 1.5 5.1 
7 467 18.2 3.9 9.0 452 18.9 4.2 9.4 
8 531 31.7 6.0 7.0 402 25.0 6.2 10.8 
 Mean±SD 519±23 40.1±39.2 7.8±7.6 8.0±5.1 423±71 26.3±18.1 6.3±4.4 10.0±4.8 
 Maximum 538 108.6 21.3 18 494 65 16.2 20.5 
 Minimum 467 0 0 0 275 7.1 1.5 5.0 
 
a  % percentage of total analyzed time,  b  periodic breathing index: periodic breathing per hour   c  % percentage of total sleep time 
Table 9. Occurrence of periodic breathing according to sleep stage 
 
Stage1-2 sleep Stage 3-4 sleep Stage REM sleep  
 
Patients 
TST a 
(minutes) 
Total 
 PBs b
Total PBI c 
(n/H) Total 
minutes d
Total  
PBs e
PBI f 
(n/H) 
%Total 
PBs g
Total 
minutes d
Total 
PBs e
PBI f 
(n/H) 
%Total 
PBs g
Total 
minutes d
Total 
PBs e
PBI f 
(n/H) 
%Total 
PBs g
1 275 49 10.7 161 44 16.5 90 79 5 3.8 10 35 0 0 0 
2 494 64 7.8 445 59 8.0 92 16 2 7.5 3 33 3 5.5 5 
3 494 87 10.6 372 80 12.9 92 69 1 0.9 1 53 6 6.8 7 
4 452 69 9.2 339 67 11.9 97 41 2 3 3 73 0 0 0 
5 462 30 3.9 337 28 5.0 93 30 1 2 3 95 1 0.6 4 
6 402 71 10.6 168 48 17.1 68 116 0 0 0 119 23 11.6 32 
7 402 128 19.1 313 123 23.6 96 47 0 0 0 41 5 7.5 4 
8 405 56 8.3 282 55 11.7 98 55 0 0 0 68 1 0.9 2 
Mean 423 69 10.0 302 63 13.3 90 56 1.4 2.2 2.5 65 4.9 4.1 6.8 
  SD 71 29 4.3 97 29 5.8 9.6 31 1.7 2.6 3.3 31 7.7 4.4 10.5 
  Maximum 494 128 19.1 445 123 23.6 98 116 5 7.5 3 119 23 11.6 32 
  Minimum 275 30 3.9 161 28 5.0 68 16 0 0 0 33 0 0 0 
. 
a  total sleep time,  b  total number of periodic breathings during sleep,  c  total periodic breathing index: total numbers of periodic breathing per hour during total sleep,  
d  total minutes in each sleep stage,  e total numbers of periodic breathing in each sleep stage,  f  total numbers of periodic breathing per hour in each sleep stage 
g  % percentage of total periodic breathing in each sleep stage 
 
 
 
 Table 10. Occurrence of arousals during periodic breathing according to sleep stage 
Stage 1-2 Stage 3-4 Stage REM  
 
Patients 
Total  
PBs a
Total 
arousals b
%PB 
 MA c
AI d Total 
PBs a
Total 
arousals b
%PB 
 MA c
AI d Total 
PBs a
Total 
arousals b
%PB  
MA c
AI d
1 44 90 22.7 33.5 1 10 0 7.6 0 3 - 5.2 
2 59 241 22.0 32.5 2 1 0 3.8 0 5 - 9.0 
3 80 239 32.5 38.5 1 3 0 2.6 6 14 0 15.9 
4 65 220 29.2 38.9 2 4 0 7.9 0 12 - 11.4 
5 28 222 42.8 39.5 1 3 0 7.9 1 14 0 11.4 
6 48 40 29.2 17.5 0 0 - 0 23 4 0 2 
7 123 172 17.8 33 0 2 - 2.5 5 2 0 4.4 
8 55 107 23.6 22.7 0 1 - 1.1 1 12 0 2 
Mean 62.8 166.4 22.5 32.0 0.9 3.0  4.2 4.5 8.3  7.7 
  SD 28.7 77.6 7.8 8.0 0.8 3.1  3.2 7.8 5.2  5.0 
  Maximum 123 241 42.8 39.5 2 10  7.9 23 14  15.9 
  Minimum 28 40 17.8 17.5 0 0  0 0 2  2 
 
a  total number of periodic breathings in each sleep stage  b  total arousals in each sleep stage   
c  % percentage of arousals occurring during periodic breathing  d arousals index:  arousals per hour 
 
Table 11. Results of polysomnography, SaO2 and TcPCO2 for patients with or without PB 
 
 Patients with PB 
n=8 
Patients without PB 
n=12 
P values 
PBI 10.1±4.8 1.8±1.5 <0.0001 
TST(min) 423±71 361±46 0.052 
SE 75.1±11.3 68.8±8.2 0.195 
%S1 15.1±4.2 15.4±5.3 0.866 
%S2 55.1±12.6 49.5±8.8 0.302 
%S34 14.5±9.6 21.7±9.6 0.12 
%Srem 15.4±15.8 13.5±6.7 0.535 
ODI 10.8±6.7 3.8±4.6 0.01 
SaO2min 76.4±8.1 82.3±4.0 0.042 
SaO2mean 89.5±3.4 91.3±1.7 0.129 
TcPCO2mean(mmHg) 42.8±5.6 44.9±6.0 0.468 
TcPCO2median(mmHg) 43.3±5.6 45.0±6.1 0.565 
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